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The enzyme dehydroquinate dehydratase (DHQase) is responsible for catalysing the 
reversible dehydration of 3-dehydroquinic acid (dhq) to 3-dehydroshikimic acid 
(dhs). Two completely unrelated enzymes, designated type I and type II, are capable 
of performing this reaction. Type I enzymes, exclusively make up part of the seven-
step biosynthetic shikimate pathway, found in plants, bacteria, fungi and parasites. 
This pathway is responsible for the production of chorismic acid, the key precursor 
to the vast majority of aromatic compounds including the three aromatic amino 
acids. Type II enzymes are found in both the shikimate pathway and the catabolic 
quinate pathway. The quinate pathway allows soil microorganisms to utilise the 
abundant plant metabolite, quinic acid as a carbon source in the absence of other 
carbon sources. 
In fungi the central five steps of the shikimate pathway are fused into a single protein 
called the AROM enzyme. This has been shown to be related to the QUTA and 
QUTR proteins found in fungi which are responsible for the activation and 
repression of the transcription of enzymes found in the quinic acid utilisation 
pathway. The shikimate and quinate pathways therefore appear to be linked by a 
complex web of evolutionary relationships. 
Here research attempting to understand more fully the active mechanism of type I 
dehydroquinase from S. typhi is discussed. This research utilises molecular 
biological, biochemical and crystallographic techniques. Crystallographic trials of 
the dehydroquinase like domain of QUTR from A. nidulans are also discussed. 
After literature review in chapter 1 and explanation of experimental techniques used 
in chapter 2, chapter 3 describes the production of active site mutants of type I 
dehydroquinase from S. typhi. In this chapter the kinetic analysis of produced mutant 
enzyme is shown and reveals that Glu 86 plays a significant role in the mechanism 
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of this enzyme. In chapter 4 crystallisation of type I dehydroquinase and its 
subsequent diffraction is described. Crystals are shown to have an unusual packing 
disorder and an analysis of this is shown. Chapter 5 describes and discusses the 
structures of five different crystal forms of wild type type I dehydroquinase from S. 
lyphi. One of these structures reveals movement of the active site residue His 143 
and shows its importance in the mechanism of type I dehydroquinase. In chapter 6 
crystal structures of mutant enzyme are described and discussed. Mutant residues are 
shown to mimic the wild type positioning of Glu 86. The structure of one of these 
mutants is shown to contain the weak type I dehydroquinase inhibitor acetate. The 
binding mode of this inhibitor is described and the structure serves to show what is 
needed for the closure of the Hh loop. In chapter 7 kinetic studies of putative 
dehydroquinase inhibitors are described and discussed. The high degree of 
specificity of type I dehydroquinase is shown and the crystal structure of an inhibitor 
in the active site of type I dehydroquinase is described. This structure reveals Lys 
170 to be an important residue in inhibitor binding and important to the enzyme 
specificity. In chapter 8 crystallisation trials of the dehydroquinase like domain of 
the QUTR protein are discussed. Initial crystallisation conditions and a description 
of their optimisation is given. In chapter 9 all results are discussed including the 
unusual packing of type I dehydroquinase from S. typhi and the implications of 
results to explaining the enzymes reaction mechanism. It is argued that the active site 
residue His 143 acts as the general base in the reaction mechanism. A reaction 
mechanism for type 1 dehydroquinase is proposed based on substrate conformational 
change. 
In appendix 1 the structural solution and refinement of cytochrome c4 from 
Pseudomonas aeruginosa is described. The structure is described and compared to a 
previously solved cytochrome c4 from Pseudomonas stutzeri. The structures are 
revealed to differ in their water content in one of the haem binding pockets. A 
structural based theory for the difference between the electric potentials of these two 
proteins is proposed. 
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Li 	The shikimate pathway 
The prc-chorismate (shikimate) pathway links the metabolism of carbohydrates to 
the biosynthesis of aromatic compounds [1]. The shikimate pathway is a seven step 
enzyme-catalysed pathway responsible for the conversion of erythrose-4-phosphate 
(E4P, obtained from the pentose phosphate pathway) and phospho-enol pyruvate 
(PEP, obtained through glycolysis) to chorismic acid. This is the common precursor 
to the large majority of aromatic compounds including the three aromatic amino 
acids: tyrosine (Tyr), tryptophan (Trp) and phenylalanine (Phe) as well as para-
aminobcnzoic acid (Scheme 1) [2]. All pathway intermediates may be considered 
branch point compounds that may serve as substrates for other metabolic pathways 
[1, 2]. 
The three aromatic amino acids can be synthesised de novo by algae, bacteria, plants, 
fungi and parasites [2, 3, 4]. Animals do not possess the shikimate pathway and, of 
the three aromatic amino acids, can only synthesise tyrosine through the 
hydroxylation of phenylalanine. Animals must gain phenylalanine and tryptophan 
through the diet [2]. The absence of this pathway in animals makes the shikimate 
pathway a potential target for chemotherapeutic attack. An example of this is 
glyphosate (N-phosphornethylglycine). This is a specific inhibitor of the shikimate 
pathway and acts only on the pathway's penultimate enzyme; EPSP synthase. 
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Glyphosate is in general use as a non-specific herbicide [5]. Glyphosate has also 
been shown to be capable of inhibiting microbial growth [2] and shikimate pathway 
attenuated strains of S. typhi have also shown success as potential vaccines [6]. 
The intermediates of the shikimate pathway are all similar in structure yet each is 
recognised absolutely by a single enzyme on the pathway. A variety of chemical 
conversions are catalysed by the enzymes making up this pathway. These range from 
reduction and phosphorylation steps to complex condensations and stereo chemically 
unusual elimination reactions (scheme 1.) [3]. 
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Scheme 1.1 	Schematic depiction of the reactions that take place in the quinic acid 
utilisation pathway (top) and the shikimate pathway (bottom). Enzymes of the quinic acid 
pathway are depicted by letters, A = quinate dehydrogenase, B = type II dehydroquinate 
dehydratase, C = dehydroshikimate dehydratase. Enzymes of the shikimate pathway are 
depicted by numbers, 1 = 3-DAHP synthase, 2 = DHQ synthase, 3 = Type I DHQase, 4 = 
shikimate dehydrogenase, 5 =shikimate kinase , 6 = EPSP synthase, 7 = chorismate 
synthase. 
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1.2 	Organisation of the shikimate pathway 
In the shikirnate pathway differences arise in the genetic organisation of the enzyme 
activities that catalyse the reactions and in their regulation [7]. 
In bacteria the large proportion of species so far studied have shown the enzymes of 
the pathway to be mono-functional with no evidence of association in vivo. The 
genes of these enzymes are scattered throughout the genome [7]. Exceptions to this 
are Mycobacterium tuberculosis, Ainycolatopsis met hanolica and Staphylococcus 
aureus. Here the genes encoding the enzymes 3-dehydroquinate synthase (DHQ 
synthase) and 3-dehydroquinate dehydratase (DHQase I dehydroquinase) are closely 
linked [8, 9, 10]. 
In eukaryotes some of the encoded enzymes appear to be more highly organised than 
in prokaryotes. Eukaryotes manifest a trend towards the production of 
multifunctional enzymes with different combinations of activity domains [11]. 
In plants the DHQase and shikimate dehydrogenase enzymatic functions are fused 
into a single bi-functional enzyme [12]. 
In microbial eukaryotes the enzymes that are responsible for steps 2 to 6 (DHQ 
synthase to EPSP synthase, Scheme 1) in the pathway are fused into a single 
polypeptide. This is called the AROM protein and takes the form of a dimer of 
identical subunits [13, 14]. 
Amino acid comparisons between microbial genes and those of bacteria suggest a 
common ancestry, with the genes encoding the AROM protein evolving through 
multiple gene fusions [15]. The AROM enzyme therefore appears to be a mosaic of 
mono-functional domains connected by some extra amino acid linkers [16]. 
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1.3 	Regulation of the shikimate pathway 
Regulation of the shikimate pathway takes place at two major points on the pathway. 
The first of these points occurs in the production of DAHP from PEP and E4P. 
Bacteria and fungi contain three independent DAHP synthase isozymes, feedback 
regulated by L-phenyla!anine, L-tyrosine and L-tryptophan respectively [17, 18]. In 
plants, metabolic regulation of DAHP synthase appears to occur at the genetic level 
In E. co/i the shikimate kinase enzyme is produced by the aroL gene. The expression 
of this gene is under the control of the tyrR regulator gene [19]. Therefore the 
shikimate pathway is regulated at both transcriptional and allosteric levels. 
1.4 	Shikimate pathway branches 
All the intermediates of the main trunk of the shikimate pathway are potential branch 
points leading to other metabolic pathways [1]. The branches of the shikimate 
pathway are responsible for the production of a great number of products. These 
include metal chelators, vitamins E and K, folic acid, plastoquinone, 3-hydroxy-5-
arninobcnzoate and 3 -aminobenzoate [3]. 
Of particular interest to this discussion is the link between the shikimate pathway 
and the catabolic quinic acid utilisation pathway. This three enzyme pathway is 
responsible for the catabolism of quinic acid to protocatechuic acid (PCA). Both 
pathways (Scheme 1) share the two metabolites 3-dehydroquinate (dhq) and 
dehydroshikimate (dhs). 
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1.5 	The quinic acid utilisation pathway 
Quinic acid is an abundant carbon source (constituting about 10% by weight of 
decaying leaf litter) which may be utilised as an alternative carbon source by many 
fungi (as exemplified by Aspergillus nidulans and Neurospora crassa) via the quinic 
acid utilisation (qut) pathway [14]. 
Three enzymes are required to convert quinic acid to protocatechuic acid: quinate I 
shikimate dehydrogenase, DHQase and shikimate dehydratase (Scheme 1). These are 
induced by the presence of quinic acid when it is supplied exogenously as the sole 
carbon source. The quinic acid utilisation pathway is subject to carbon catabolite 
repression when quinic acid is supplied as a mixture with other preferred carbon 
sources [20, 211. This repression implies that the enzymes involved in this pathway 
are highly regulated [14]. 
1.6 	Quinic acid utilisation pathway control 
Three proteins are responsible for the control of the quinic acid pathway enzymes. 
The first of these is a permease (encoded for by qut D in A. nidulans, qa-Y in N. 
crassa) which mediates the entry of quinic acid into the mycelium at neutral pH [22, 
23]. 
Genetic and biochemical analysis of quinic acid non-utilising mutants has shown 
that the qut genes map in a cluster and that two genes, qutA and qutR, are 
responsible for mediating the regulation of pathway enzyme production in A. 
nidulaiis (qa-IF and qa-IS in N. crassa). This regulation is at the level of 
transcriptional control [21, 24, 25]. 
The qiilA / qa-IF gene encodes a positively acting regulatory protein, QUTA whilst 
the quiR I qa-IS gene encodes a negatively acting regulatory protein, QUTR. 
The QUTA protein in A. nidulans controls the production of its own mRNA as well 
as that of the qutR repressor gene. A similar situation occurs in N. crassa [23, 26]. 
The QUTA protein contains a putative zinc finger binding motif that may bind to 
variants of a 16 nucleotide motif found in the promoters of pathway genes. A region 
of highly localised negative charge at the extreme C-terminus may act as a 
transcription activation domain [25, 26, 27]. 
The QUTR protein contains no recognised DNA binding motifs [28] and so is not 
thought to inhibit transcription of pathway enzymes or the QUTA protein by binding 
directly to promoter regions. It is also therefore unlikely that it acts as an activator of 
the transcription of a secondary repressor protein. There has been no indication of 
such a protein in mutant screens [14]. 
It is more likely that the QUTR protein binds directly to the QUTA protein by direct 
protein to protein interaction and in doing so represses the function of the QUTA 
activator by blocking its DNA binding ability [29]. 
It is proposed that the binding of one or more of the metabolites of the quinic acid 
utilisation pathway may negate the effect of QUTR. This repression may be the 
effect of allosteric changes to QUTR caused by the binding of a metabolite [28] 
(Section 1.9). 
1.7 	Mechanistic studies of dehydroquinases 
As may be seen from Scheme 1, the reversible dehydration of 3-dehydroquinic acid 
to 3-dehydroshikimic acid is common to two pathways, the biosynthetic shikimate 
pathway and the catabolic quinate pathway [3]. 
Two distinct classes of dehydroquinase (types I nd II) are responsible for catalysing 
this transformation. Type I enzymes exclusivJy play a role in the shikimate 
pathway, whereas type II enzymes have both biosynthetic and catabolic roles [30]. 
The reaction of 3-dehydroquinic acid to 3-dehydiushikimic acid takes places without 
enzyme catalysis. In this case the reaction invoives the loss of the acidic pro - S 
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hydrogen from C2 of the substrate resulting in an anti elimination and is the 
preferrcd stereochemistry [31]. The reaction catalysed by the type II enzyme has 
been shown to also follow this stereochemistry [32, 33]. In contrast the reaction 
catalysed by the type I enzyme has been showr to involve the loss of the pro - R 
hydrogen from C2 corresponding to an overall s'ii elimination [34]. 
The mechanism of the type I dehydroquinase has been shown to involve an imine 
interiiediate stage (Schiff base) between the substrate and an active site lysine 
residue [35]. The role of the Schiff base is to act as an electron sink following proton 
abstraction of the C2 pro - R proton. The SLhiff base may also play a role in 
distorting the carbocyclic ring of dehydroquin : to render the C2 pro - R proton 
more reactive (scheme 1.2)[33]. 
In contrast to this there is no evidence for the type II enzyme utilising a covalent 
intermediate in its reaction mechanism which appears to proceed through an enolate 
intermediate [30, 36]. 
Enzymological and biophysical characterisation of type I and II dehydroquinases 
revealed no sequence or structural homology. 	c type I enzymes form dimers of 
monomer molecular weight of about 27 kilodaitons. The type II enzymes form 
dodecamers of monomer molecular weight of at)Lit 16 kilodaltons. These enzymes 
therefore represent an unusual case of convergei volution [301. 
The type I and type II enzymes also differ in their kinetic parameters (Table 1.1) 
although their kcat/Km  constants are surprisingly similar [30]. 




135 	 1300 
1(niQiM) 	 16 	 150 
kcat/Kfl1 (s°  M) 	8.4 x106 	 8.7x106 
Table 1.1 Kinetic constants for type I and type II DHQases at pH 7.0 and 25°C. (Data taken 
from Kloanthous eta/[30]) 
Chemical modification and site-directed mutagenesis studies on the type I enzyme 
implicated some residues as being involved in or around the active site 
Reduction of the Schiff base intermediate with NaBH4 followed by digestion of the 
labelled E. coli type I enzyme allowed the determination of the protein sequence 
around the imine forming active site lysine. This was found to be lysine 170, a lysine 
that is present in all sequenced type I enzymes [35]. 
It was also observed that irreversible binding of dehydroquinate to the type I enzyme 
with NaBH4  conveyed almost complete protease resistance to the enzyme. In 
addition it was observed that the melting temperature was increased and the 
concentration of guanidine hydrochloride required to unfold the ligand-linked 
dehydroquinase is 3-4 fold greater than that of the unmodified protein. Indicating 
significant conformational stability is conferred to the enzyme by the ligand [37, 38]. 
A mechanism for the action of the type I enzyme was proposed in which a general 
base was implicated as playing a part in the mechanism (Scheme 1.2). 
HO 
__ 	 __H JNH 
Type I 	












02C 	 H - 	-02C — OH 
OH 	 0- 
H 
Scheme 1.2 Proposed mechanisms for the enzyme catalysed conversion of type I 
dehydroquinate (1) into dehydroshikimate (2) catalysed by type I and type II 
dehyroquinases. (Taken from Harris [36].) 
It has been suggested that this general base may be His 143 [39]. Met 205 and Arg 
213 were also implicated as being present in the active site of the type I enzyme with 
Arg 213 maybe being involved in substrate binding [40]. 
Mutagenesis studies on active site residues confirmed the role of Lys 170 as being 
the imine forming lysine, through the mutant's complete inactivation [41]. The 
ability of ligand to bind was not greatly affected by this mutation suggesting that the 
primary role of Lys 170 is in the catalytic mechanism. Mutagenesis also ruled out 
Met 205 as playing a role in the catalytic mechanism or in direct ligand binding, but 
did further Support its presence in the active site nding pocket [41]. The His 143 to 
Ala mutant caused catalysis of the enzyme to be stalled. The role of His 143 would 
appear to be more complex than previously thought since substituting it for alanine 
increases the enzyme's affinity for both substrate and product, drastically slows 
down the rate of product accumulation in the forward direction, and stalls the 
hydrolytic release of product from the active site [41]. 
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1.8 	Shikimate pathway and quinic acid utilisation 
pathway enzyme structures. 
With the exception of chorismate synthase examples of all the enzymes found on the 
shikimate pathway have been crystallised and their structures solved [42, 44, 46, 98, 
99, 100, 101, 102]. In addition the quinic acid utilisation pathway enzyme; type II 
dehydroquinase has been crystallised and its structure solved [43, 44, 45]. 
1.8.1 	Structure of type II dehydroquinase. 
The type II subunit was found to be arranged with a similar overall topology to 
flavodoxin, consisting of a five-stranded parallel 13—sheet core flanked by four 
a—helices (figure 1. 1). 
Figure 1.1. Cartoon of type 11 dehydroquinase structure from M. tuberculosis. 
The type II monomer forms an overall dodecamer arranged tetrahedrally as a 
tetramer of trirners [47]. This was shown in the M. tuberculosis structure and has 
most recently been shown in the S. coelicolor structure (Figure 1.2) [45]. 
In the M. tuberculosis structure there is a break in the polypeptide chain between 
residues 19 to 24 that is due to poor electron density. The residues in this region are 
known to form a flexible loop [48] and both Arg 19 and Tyr 24 have been identified 
as being essential for enzyme activity [40]. 
Figure 1.2. Cartoon of the dodecamer of S. coelicolor. The twelve subunits of the 
dodecamer form four trimers arranged in a tetrahedral way. Each trimer is coloured 
differently. 
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1.8.2 	Structure of type I dehydroquinase from S. typhi. 
The structure of the borohydride-reduced substrate-enzyme complex of type I 
dehydroquinase from S. typhi was determined to 2.1 A using multiple isomorphous 
replacement [44]. The structure is dirneric. 
The overall monomer topology is of an eight stranded 13—barrel surrounded by 
a—helices (Figure 13). This structural topology was first identified for triose 
phosphate isomerase and is commonly known as a TIM barrel. This barrel structure 
is one of the most observed folds in proteins, with nearly 500 entries deposited in the 
Protein Data Bank. This fold has also been found in other enzymes which form an 
irnine intermediate such as the class I aldolases. 
In addition to the eight strands forming the J3—barrel, there are two, small anti-
parallel 13—strands at the N-terminus forming a 13—hairpin which effectively closes off 
one end of the barrel. The substrate is stacked parallel to Phe 225, which is also in 
the lower N-terminal side. This has the effect of blocking any possible attack on the 
substrate from below so that only a cis elimination mechanism for water is possible. 
The opposite end of the barrel provides the means by which the substrate can reach 
the active site of the enzyme. 
13 
Figure 1.3. Monomer structure of type I dehydroquinase from S. typhi. x—helices are 
coloured red and their designation is in uppercase. 3—strands are coloured yellow and their 
designation is in lower case. dhs and Lys 170 side chain are in ball and stick. 
The active site is located towards the centre of the barrel, with the Schiff base 
forming Lys 170 located on 13—strand f, (as it is in several other Schiff base forming 
enzymes, but not in transaldolase where the active site lysine is on strand d rather 
than strand f). 
In the active site a number of residues are seen to orientate the substrate (Figure 1.4). 
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Figure 1.4. Interactions within the active site of reduced type I dehydroquinase from S. 
typhi. 
His 143 is placed proximal to the C2 side of the substrate. Gin 236 and Arg 213 
interact with the carboxylic 05 of the substrate and Arg 213 and a water molecule 
w461/w452 with the carboxylic 04. As previously mentioned Arg 213 had been 
implicated in binding the carboxylate group of dehydroquinate. Arg 48 and Glu 46 
interact with the hydroxyl group of CS (03); Glu 46, Arg 82 and water molecule 
w409/w410 with the C4 hydroxyl group 02 and His 143 with the irnine NZ of Lys 
170. The water molecule w 409 (A monomer) also interacts with the imine NZ of 
Lys 170 and with Glu 46. 
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His 143 appears to be at the centre of hydrogen - bonded triad, flanked by Lys 170 
and Glu 86. The location of His 143 next to the a—nitrogen of Lys 170 argues 
strongly for His 143 playing a role in the formation / hydrolysis of the Schiff base as 
previously suggested by niutagenesis. However the distance of His 143 from the C2 
proton suggests that contrary to earlier expectations it may not be involved in the 
general base-catalysed proton abstraction of the pro - R proton. 
NMR data shows that His 143 is unlikely to carry a positive charge suggesting that 
the abstracted proton may shunted to Glu 86 [49]. 
The monomers of Type I dehydroquinase from S. typhi form a dimer with helices F, 
G and H at the dimer interface (figure 1 .5). 
Figure 1.5 Cartoon of the dimer structure of type I dehydroquinase from S. typhi. U.—helices 
are coloured red and 13—strands are coloured yellow. The borohydride reduced product 
covalently attached to Lys 170 is in ball and stick. 
16 
The chains of each monomer are arranged side-by-side, with the active sites facing 
in opposite directions. Four residues are involved in the packing of the dimer (figure 
1.6). These four residues form two hydrogen bonds and two salt bridges [46]. 
Figure 1.6 Interactions in the dimer interface of type I dehydroquinase from S. typhi. 
1.8.3 	Comparison of native and borohydride reduced 
type I dehydroquinase structures 
More recently the structure of native type I dehydroquinase from S. typhi was solved 
[46] and comparison of native and borohydride reduced forms has revealed some 
further interesting features of the enzyme. 
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The active sites are alike, with the exception of the Met 203 and Arg 213 side chains 
in the native crystal form. In the native form both of these side chains are displaced 
towards the exit of the active site. 
The dimer interface was also found to be alike in both native and product bound 
forms. Superimposition of dimers from different forms shows no significant RMS 
deviation in C-alpha atom positioning, suggesting the dimer interface is relatively 
stable and that no significant 'hinge' movement is occurring. 
The most obvious and probably significant difference between the structure of the 
native enzyme and the structure of the enzyme with product covalently bound is in 
the positioning of the Hh loop, comprising residues 227 to 238 (figure 1.7). 
Figure 1.7. Overlay of borohydride reduced product bound structure and native type I 
dehydroquinase structure. The Hh loop is coloured green for the native structure and grey 
for the reduced structure. 
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There are several small loops connecting n—strands to a—helices in this structure but 
the Hh loop is significantly larger than the others. Most loops contain an average of 
6 residues whilst this loop contains 12. 
This loop is located at the C-terminal end of the barrel, adjacent to the active site 
entrance. The position this loop adopts appears to be dependent upon the presence or 
absence of substrate and seems to be responsible for shielding the active site against 
solvent, increasing the hydrophobic nature of the active site core. 
A residue on this loop (GIn 236) is involved in the binding of the substrate by the 
formation of a hydrogen bond to the substrates carboxyl group (Figure 1.4). 
In the native form the Hh loop is open allowing the substrate access to the active 
site. The loop in this open form appears to adopt several conformations as suggested 
by poor electron density and larger than average B-factors. Although the closed 
conformation of this loop is thermodynamically favourable Lee et at [46] have 
suggested that Gly 235 interacts with the C-terminus Ala 252 to form a weak catch 
and so holds the loop open in the native enzyme. 
1.9 	Comparison of QUTA and QUTR with the AROM 
Protein 
The pentafunctional AROM enzyme is homologous throughout its length with the 
QUTA and QUTR proteins. The QUTA protein is homologous with the N-terminal 
two domains and the QUTR protein is homologous with the C-terminal two domains 
of the AROM protein [26]. 
The two C-terminal domains of the QUTR transcription repressor protein have 
similar physical characteristics to the equivalent domains of the AROM protein. One 
notable difference is that the DHQase domain of QUTR is dimeric whilst the 
equivalent domain of the AROM protein is monomeric. CD spectroscopy and 
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emission spectroscopy to probe secondary and tertiary structures has shown these 
domains in QUTR and AROM to be virtually indistinguishable [50]. 
It is proposed that the QUTA and QUTR proteins have formed through duplication 
and cleavage of the AROM protein (Figure 1.8) [51]. Modelling of the QUTR 
DHQase like domain sequence onto the dehydroquinase structure from S. typhi is 
consistent with this (D. Cronin, persona! communication). 
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Figure 1.8 Modular structure of the enzymes and regulatory proteins comprising the quinate 
and pre-chorismate shikimate pathways in A. nidulans. The boxes denoted aro designate 
genes from bacteria encoding monofunctional shikimate pathway enzymes: aroA, E. coli 
EPSP synthase (EPSPS); aroB, E. coli DHQ synthase (DHS); aroD, E. coli type I 3-
dehydroquinase (DO); aroE, E. coil shikimate dehydrogenase (SDH); aroL, E. coli shikimate 
kinase (SK); and aroQ, M. tuberculosis type II 3-dehydroquinase (Doll). AROM designates 
the modular structure of the AROM protein of A. nidulans which is specified by the aroA, B, 
D, E and L genes. The boxes denoting the genes of the qut pathway are: qutA, activator; 
qutB, quinate/shikimate dehydrogenase (QDH); qutD, permease; qutE, type II 3-
dehydroquinase (D011); qutG, possibly a phosphatase: and qutR, repressor. The genes 
encoding the quinate pathway activator and repressor proteins are proposed to have arisen 
by duplication of the aro genes followed by cleavage in the DNA sequence specifying the C-
terminus of the EPSP synthase domain (aroA equivalent). The aromA sequence encoding 
the DHQ synthase domain in the duplicated copy is proposed to have undergone an event in 
which the DNA sequence encoding a pre-formed zinc binuclear cluster motif (designed Zn) 
has become inserted into its N-terminus. The box denoted aroQ designates the type II 3-
dehydroquinase from M. tuberculosis. The arrows between boxes are there to indicate that 
genes denoted by the boxes are related to one another (Taken from Hawkins and Lamb 
1995 151]). 
The proposed relationship of the QUTA and QUTR proteins to the AROM protein 
has been questioned by Nicholas [52] where it is suggested that because of the low 
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level of sequence homology between QUTA and AROM the proposed relationship 
between them is without foundation. 
1.10 	Project aims. 
The aim of this project was to investigate the chemical detail of the mechanism of 
the type I enzyme from S. typhi. 
Various molecules were tested for their binding properties, both in crystal (by crystal 
soaking and co-crystallisation) and by assay to examine the relationship between 
various ring substituents and the binding activity. Details of interactions within the 
active site may aid in explaining the exquisite discrimination for the substrate and 
the product (Keq = 15). This may also allow the further prediction of other 
competitive inhibitors. 
Linked to this is the characterisation of site-directed mutants of the S. typhi enzyme. 
Characterisation was performed in the above way in an attempt to clarify the role of 
amino acid residues within the active site. This too should aid in the understanding 
of the chemical mechanism and binding. 
Related to this are comparative studies between the QUTR DHQase like domain of 




Materials and Methods. 
Materials. 
2.1 Media and supplementation for Ecoli. 
Bacto tryptone, yeast extract and agar were bought from Difco. 
Luria Broth [53,63]. 
Bactotryptone 1 Ugh 
Yeast extract 5g11 
NaCl lOg/i 
Luria Agar. 
Luria agar was made by addition of 1 5g/1 agar to Luria broth, prior to sterilisation. 
Antibiotic stock solutions. 
Amp icillin 
Stock concentration 10mg/mi 
Final concentration 100 tg/MI 
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2.2 	Buffers and Solutions. 
Tris-acetate-EDTA (TAE) electrophoresis buffer (50X). 
2M Tris(2-hydroxy-3 , 5 -dirnethylbenzyl)amine base (Tris base) 
1M Sodium acetate 
50mM ethylenediamminetetraacetate (EDTA) 
Solution adjusted to pH 8.2 using glacial acetic acid. 
Agarose gel loading buffer (lOX stock). 
Bromophenol blue 0.25% 
Xylene cyanol FF 0.25% 
Ficoll (type 400) 25% 
23 	SDS-polyacrylamide gels (modified from Laemmli 
[54,63]). 
Discontinuous buffer system 
Separating gel; 375mM Tris-HCl pH 8.8, 0.15% SDS 
Stacking gel; 125mM Tris-HC1 pH 6.8, 0.1% SDS 
Running buffer; 25mM Tris-glycine pH 8.12, 25mM glycine, 0.1% SDS 
Separating gel buffer (2X stock). 
Tris 90.6g 
Sodium dodecyl sulphate (SDS) 2.Og 
pH to 8.8 with HC1, H20 to 1 litre 
Stacking gel buffer (2X stock). 
Tris 30.24g 
SDS 2.Og 
pH to 6.8 with HCI, H20 to 1 litre 
Ammonium persuiphate (40mg/mi). 
40mg Ammonium persuiphate, H20 to lml, made fresh on day of use. 
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Sample buffer (2X stock). 
Stacking buffer (X2) 50m1 
SDS 4.Og 
Glycerol 20m1 
1% bromophenol blue 1 ml 
-rnercaptoethanol 5 ml 
H20 to lOOml 
Separating gel (volumes for 35m1). 
Acrylamide (40% including bis 37.5:1 ratio) 
7.5% gel 6.25m1 
10% gel 8.5m1 
12.5% gel lOmi 
Separating gel buffer (2X) 1 7m1 
H20 to 34m1 
De-aerated and then the following added 
20mg/mi ammonium persulphate 0.9m1 
Tetramethylethylenediamine (TEMED) 20 jil 




H20 to 1 litre 
Stacking gel mix (for 20m1). 
Stacking gel buffer(x2) I OrnI 40% acrylamide solution 2.5% 
H20 7m1 
De-aerated and then the following added 
20mg/ml Ammonium persulphate 0.5ml 
TEMED 15 jil 
MA 
Coomassie Blue staining solution. 
0.4% (w/v) Coomassie brilliant blue R 
45% (v/v) methanol 
10% (v/v) Glacial acetic acid 
Destaining solution. 
10% (v/v) methanol 
14.5% (v/v) glacial acetic acid 
10% Sodium azide solution lml 
H20 to lOOmI 
Stored at 4 degrees 
Methods. 
	
2,4 	Maintenance of E.coli strains. 
E.coli strains were grown routinely on Luria agar for 12-16 hours at 37°C. Media for 
strain bearing plasmids was supplemented with ampicillin at a final concentration of 
100 tg/ml. 
Plates of E.coli were stored for up to four weeks at 4°C degrees. Plasmids were 
stored in aqueous solutions at -20°C and were not maintained in transformed E.coli 
strains for longer than 2-3 days. 
2.5 	Growth of E.coli in liquid culture. 
For DNA isolation, E.coli strains were grown at 37°C in Luria broth. 
For small scale preparation of plasmid DNA, 2m1 cultures supplemented with 100 
jig/ml ampicillin were grown at 37°C in sterile 50ml capped boiling tubes for 
approximately 8 hours with agitation at 160 rpm. 
Cells were harvested by centrifugation for 13 seconds at 13,000 rpm in 1.5ml 
microfuge tubes. 
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For large scale plasmid preparations a 10m! starting culture was grown for 
approximately 8 hours and then transferred to 500m1 of Luria broth supplemented 
with 100 jtg/ml ampicillin in a 2 litre baffled flask. Incubation was at 37°C for about 
15 hours with agitation at 160rpm. The cells were harvested by centrifugation in a 
Beckman JA 14 rotor at 5000 rpm for 10 mins at 4°C. 
General molecular biology techniques. 
2.6 	Phenol/Chloroform extraction [55, 62]. 
A phenol/chloroform/iso-amyl alcohol mix from Sigma was equilibrated to pH 8.0 
with Tris buffer. 
Three quarter volumes of this mix were added to the DNA solution in a 1.5 ml 
microfuge tube. The two phases were vortexed for 5 minutes resulting in the 
denaturation of contaminating protein. The aqueous and organic phases were 
separated by centrifugation at 13,000 rpm for 5 minutes. The upper aqueous layer, 
that contained the DNA was extracted and placed in a fresh microfuge tube. Care 
was taken to not disturb the white layer of denatured protein at the interface. 
Traces of contaminating phenol were removed from the DNA solution by the 
repeating of the above procedure with chloroform and not the 
phenol/chloroform/iso-amyl alcohol mix. 
The DNA sample was then ethanol precipitated in order to further purify and 
concentrate the nucleic acids. 
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2.7 	Ethanol Precipitation [55,62]. 
Nucleic acids in aqueous solution were routinely recovered using this procedure. 
The volume of the DNA solution was estimated and 0.05 volumes of potassium 
acetate (pH5.6) were added, followed by 2.2 volumes of ethanol. This solution was 
stored at -20 or -80°C for a minimum of 30 minutes. The addition of the salt could be 
omitted for solutions that already had high ionic strength ie; alkaline lysis plasmid 
preparations or diluted caesium chloride solutions from density centrifugations. The 
precipitated DNA was pelleted by centrifugation at 13,000 rpm for 20 minutes. 
For larger DNA solution volumes the ethanol was substituted for 0.6 volumes of 
propan-2-ol and incubation at -20°C for 30 minutes. The DNA was pelleted in 50 ml 
tubes in a Beckman JA-20 rotor at 10,000 rpm for 30 minutes. 
The supernatant was removed with care being taken not to disturb the pelleted DNA. 
The pellet was washed with 70% (vlv) ethanol to remove excess salts. The pellets 
were then dried in a centrifugal evaporator in the case of microfuge tubes or a drying 
oven for larger volumes. 
The dried pellets were then dissolved in sterile de-ionised water. 
2.8 	Ligation [56,62]. 
DNA ligase has the physiological role of sealing single-stranded nicks in DNA. T4 
ligase has been used extensively for covalently linking restriction fragments with 
either "sticky" or "blunt" ends. 
Ligations were carried out in 10 microlitre volumes containing lx ligation buffer, 
with 1 unit of T4 DNA ligase (BRL). Blunt ended molecules were ligated together 
with 2 units of ligase per reaction and the concentration of ATP increased to 2 mM. 
The total concentration and relative amount of each DNA species in the reaction 
mixture for optimised ligation can be estimated theoretically. 
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In practise, a normal plasmid ligation consisted of 4 parallel tubes, all with a 
constant concentration of plasmid DNA and either no fragment, or a 1.5, 3 or 6 fold 
molar excess of fragment DNA. 'Blunt ended" ligation reactions ligated efficiently 
when incubated at room temperature for 4 to 6 hours. 
Recombinant DNA molecules were recovered by transformation into a high 
transformation frequency strain of E.coli, such as SK3430 [57] or HB101 [58]. 
2.9 	Transformation of E. coil. 
Most methods of E.coli transformation including those used here are based on the 
observations of Mandel and Higa [59] who demonstrated that the uptake of plasmid 
DNA by cells could be enhanced by the treatment of the cells with calcium chloride. 
Other methods of transformation, such as electroporation are also used [60]. 
A 2m1 aliquot of stationary phase culture was inoculated into 30m1 of Luria broth in 
a 250 ml conical flask. The culture was incubated at 37°C with agitation at 160rpm 
to increase aeration. At mid log phase (OD500 , was 0.6 - 0.8) 1.5m1 aliquots of this 
culture were put into 1.5m1 microfuge tubes. 
The cells were pelleted by centrifugation at 13,000 rpm for 15 seconds and the Luria 
broth removed. The cells were washed by re-suspension in 450il of ice-cold 10 mM 
MOPS-NaOH pH 7.0. After a further centrifugation step and the subsequent removal 
of buffer the cells were resuspended in 450.i1 of 10mM MOPS-NaOH, 50mM CaC12 
pH 6.5 (competence buffer). The cell suspension was incubated on ice for 90 
minutes. After a further centrifugation and buffer removal the cells were 
resuspended in 150 t1 of the competence buffer and 3l of DMSO. The transforming 
plasmid DNA was added to the cell suspension, which was then incubated on ice for 
a further 30 minutes. 
The cell mixes were heat-shocked at 65°C for 40 seconds and immediately placed in 
an ice water bath for 5 minutes. 
The cells were plated directly onto 100 jtg/ml ampicillin supplemented Luria agar 
plates and incubated at 37 °C for 18 hours. 
2.10 	Isolation of plasmid DNA from Ecoli. 
Plasmid DNA was isolated by a method adapted from Birnboim and Doly [61] for 
both large and small-scale preparations. 
For some large-scale preparations Qiagen midi kits were also used. Plasmid DNA 
was isolated by this method following the manufacturer's instructions. 
Small scale preparation. 
During a small scale plasmid DNA preparation a transformed colony was picked 
with a sterile toothpick and placed in 2m1 of Luria broth supplemented with 
ampicillin. This was incubated at 37°C with agitation at 160 rpm for 8-16hrs. 
The cells were pelleted by centrifugation for 15 seconds at 13,000rpm and the 
supernatant thoroughly removed. The cells were resuspended in 100 tl of 25mM 
Tris-HC1, 10mM EDTA, 4mg/mI lysozyme (added just prior to use) pH8.0. After 
incubation at room temperature for 5 minutes, 200 p1 of freshly prepared 0.2M 
NaOH, 1% (w/v) SDS was added to each tube. The contents were mixed by 
inversion and then incubated on ice for 5 minutes before the addition of 150 tl of 
3M potassium acetate pH4.8 [62] to bring the contents to a neutral/acid pH. The 
cellular debris and chromosomal DNA were pelleted by centrifugation for 5 minutes 
at 13,000 and the supernatant that contained the plasmid DNA was transferred to a 
fresh 1.5m1 microfuge tube. 
The supernatant was extracted with phenol/chloroform to remove proteins and the 
nucleic acid recovered from the aqueous fraction by ethanol precipitation. 
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Large scale preparation. 
Except when Qiagen kits were used, large-scale preparation of plasmid DNA was a 
scaled up version of the above method. 
For each plasmid 500m1 of cell culture was grown and pelleted. The cell pellet was 
re-suspended in 15m1 of 25mM Tris-HCI, 10mM EDTA, and 4mg/mi lysozyme pH 
8.0. The suspension was incubated at room temperature for 5 minutes and then 30m1 
of 0.2M NaOH, 1% SDS was added to aid lysis and denaturation of chromosomal 
DNA, then again incubated at room temperature for 5 minutes. After 22.5ml of 3M 
potassium acetate pH 4.8 was added to precipitate proteins and chromosomal DNA 
and incubated at room temperature for 5 minutes, the mix was then centrifuged for 
20 minutes at 10000 rpm. 
The cleared lysate was poured through single ply tissue paper to separate it from the 
aggregates of protein and chromosomal DNA. Adding 0.6 volumes of propan-2-ol 
and incubation at -20°C for a minimum of 30 minutes precipitated the nucleic acids. 
This was followed by centrifugation at 10000 rpm for 30 minutes at 4°C. The nucleic 
acid pellet was washed with 70% (v/v) ethanol and dried in a drying oven overnight. 
The dried DNA was re-suspended in 9m1 of water at 65°C and 200 tl of ethidium 
bromide was added. 
The weight of solution was determined and 1.12g of CsCL was added per gram of 
solution. The solution was placed in a 14m1 "Quick seal" Beckman tube and heat-
sealed after tubes had been balanced. The tubes were then centrifuged for 24hrs at 
55,000 rpm at 20°C in a fixed angle Ti-80 rotor. The plasmid band was removed 
from the CsC1 gradient with a sterile syringe and needle. The ethidium bromide was 
removed by repeated extraction with butan-1-oi and the CsCI was extracted by 
dialysis against de-ionised water at 4°C. After final ethanol precipitation of the 
plasmid DNA a yield of around ling was typical from a 500m1 culture. 
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2.11 	Agarose gel electrophoresis [62, 63]. 
0.8% agarose was used in all cases for DNA analysis and 0.8% agarose was used for 
the purification of DNA fragments. 
DNA electrophoresis. 
For electrophoresis, Tris-acetate-EDTA (TAE) agarose gels were used. Agarose was 
melted in a microwave and cooled to 55°C before being poured into a gel former. 
The gel was allowed to set completely before being submerged in an electrophoresis 
tank containing lx TAE buffer. Agarose gel loading buffer (I Ox stock) was added to 
DNA samples and these were loaded into the gel. Electrophoresis was carried out at 
room temperature with time and potential gradient (v) varying dependant upon 
resolution required. 
Following the electrophoresis the gel was stained in 2.5 .ig/ml ethidium bromide for 
10 to 15 minutes with shaking. The DNA was subsequently visualised under long 
wavelength UV light. An image of the gel was generated on thermal paper by a 
Mitsubishi video copy processor. 
2.12 	Purification of DNA fragments from agarose gels. 
DNA fragments were purified from low melting point gels using the "freeze 
squeeze" method of Tautz and Renz [64]. Here the section of LMP agarose 
containing the desired DNA fragment is frozen and then subjected to centrifugation. 
This compresses the gel and disrupts its structure, thereby making it possible to 
recover the DNA and interstitial buffer. DNA fragments of up to 10 kilobases in 
length may be recovered using this method. 
Samples were run on LMP gels using the method above and the band corresponding 
to the desired fragment was excised. The excised gel fragment was placed in a 30m1 
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universal bottle containing about 50 volumes of 0.3M sodium acetate pH 7.0, 1 mM 
EDTA. This was wrapped in aluminium foil and gently shaken for 30 minutes. This 
removed all traces of the ethidium bromide from the gel and DNA. The gel fragment 
was then transferred to a 500 p1 microfuge tube that had been punctured in the base 
by a needle and plugged with siliconised wool. This tube was inserted into a de-
capped 1.5m1 microfuge tube and the entire assembly was incubated at -80°C for a 
minimum of 30 minutes. 
The double tube assembly was then immediately centrifuged at 13,000 rpm for 10 
minutes at room temperature. The eluate that collected in the larger of the microfuge 
tubes was pipetted into a fresh 1 .Sml microftige tube. The double tube assembly was 
centrifuged for a further 2 minutes to obtain the last traces of eluate and these were 
added to eluate already transferred to fresh tube. 
The collected eluate was centrifuged for a further 10 minutes at 13,000rpm to pellet 
any remaining contaminating agarose. 
The supernatant was pipetted carefully into a fresh tube and the DNA purified by 
phenol/chloroform extraction and recovered by ethanol precipitation. 
2.13 	Site directed mutagenesis. 
The method described by Hemsley [65] was used in this research to direct specific 
sequence changes in the plasmid pKK45 [120]. 
The polymerase chain reaction (PCR) is used to amplify the entire plasmid. Two 
primers, located on opposing strands are used and designed such that they are "back 
to back". One of these primers contains the mismatches in the sequence, which 
generates the site directed mutations. After PCRs have been performed the double 
stranded DNA product is blunt ended using the Klenow fragment followed by 5' 
phosphorylation to allow re-circulisation of the plasmid. Plasmids are then treated 
with T4 ligase before transformation into a competent E.coli strain. 
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Polymerase chain reaction (PCR) [66]. 
Polymerase chain reaction (PCR) is a powerful technique, enabling the controlled 
amplification of specific DNA strands. Two single stranded oligo-nucleotide 
primers, which flank the target DNA strand, are utilised. One of these primers is 
complementary to the 5' end of the target DNA strand with the other being 
complementary to the 3' end. 
Heating the PCR reaction mix above the melting temperature of the DNA strand 
causes the DNA strands to separate. Subsequent cooling causes the target sequence 
and the primers to anneal. The primers are present in excess causing a greater 
proportion of the target DNA to anneal to the primers than to itself. Subsequent 
enzyme catalysed polymerisation results in the production of a new DNA strand. 
Further cycles of de-naturation, annealing and extension allow an exponential 
increase in the target sequence to take place. This allows the target sequence to be 
amplified millions of fold. 
PCR reagents, enzymes and programmable thermal cyclers are all commercially 
available. Enzyme and buffer were purchased from Boehringer Mannheim, GIBCO 
BRL produced oligo-nucleotide primers and a Biornetra T3 thermal reactor was used 
to accomplish the thermal cycling. 
General reaction conditions are as below (any adjustments to this are detailed in the 
relevant sections). 
The PCR reaction mix contained 10mM tris-HC1 pH8.8, 50mM KCI, 1.5mM M902, 
0.1% (v/v) non-ionic detergent, 3.5 units of Taq XL DNA polymerase and 100 VtM 
dNTPs in a final volume of 100 .i1. Primers were added last to a concentration of 
0.15 1.iM. The risk of aerosols was reduced by centrifuging any mixes containing 
DNA after vortexing. For mutagenesis four of the above reactions were set up to 
maximise the amount of DNA produced. 
The typical conditions for production of mutant DNA consisted of an initial melt of 
94°C for 2 minutes followed by 29 cycles of annealing at 58°C for 2.5 minutes, 
extension at 72°C for 5 minutes and de-naturation for 1 minute. A final annealing 
step and 8 minute extension was followed by cooling to 4°C. Previous to the final 
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cooling stage the lid of the thermal reactor was heated to 100°C to reduce 
evaporation from the reaction mix. After this the lid was allowed to cool to room 
temperature. 
Agarose gel electrophoresis was used to establish that DNA fragments of the 
predicted molecular weight had been produced. Products were then gel purified, 
phenol/chloroform extracted and ethanol precipitated prior to further manipulations. 
At the ethanol precipitation stage products from the four separate reactions were 
pooled together. 
Klenow fragment blunt ending [62, 67]. 
Following gel purification the amplified plasmid containing the desired site-directed 
mutant was subjected to a Klenow fragment blunt ending step. This was necessary to 
remove additional base pairs at the ligation point that may have been incorporated 
during the PCR reactions. 
The purified DNA was dissolved in 29.7 tl of de-ionised water and to this solution 
the following was added. 
5 p1 nick translation buffer (0.5 tris-HC1 pH7.2, 0.1M MgSO4 lOx stock) 
5 j.il 10mM DTT (lOx stock) 
5 p12mM dNTPs 
5 p1 10mM BSA (I Ox stock) 
0.3 itl Klenow fragment (8.16 units / p1) 
The above mix was incubated at 37°C for 15 minutes. The Klenow fragment was 
subsequently removed by phenol/chloroform extraction and DNA was recovered by 
ethanol precipitation. 
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5' phosphorylation [62, 68]. 
To allow the plasmid to re-circularise the linear plasmid DNA was to 5' end 
phosphorylation treatment. The DNA recovered from Klenow treatment was 
dissolved in 23 il of de-ionised water and to this solution the following was added. 
4 il one phor all buffer (0.IM tris-acetate pH 7.5, 0.1M Mg acetate, 0.5M K acetate 
- lOx stock). 
4 jil 10mM DTT (I Ox stock) 
2 tl 10mM ATP (I Ox stock) 
1 j.tl polynucleotide kinase (6 units / il) 
This reaction mixture was incubated for 30 minutes at 37°C and then subjected to 
phenol/chloroform extraction, followed by ethanol precipitation to recover the DNA. 
Plasmid was then treated to ligation before being transformed into a competent 
E.coli strain. 
2.14 	Purification of S.typhi type I dehydroquinate 
dehydratase. 
S. typhi DHQase was purified by Prof. A.R.Hawkins, University of Newcastle, using 
the following method [118]. 
Crude cell extracts were subjected to ammonium sulphate precipitation with the 
precipitate formed from 30 - 75% being retained. The precipitate was dissolved in 
50mM Tris/HC1 buffer pH7.5 containing 1mM DTT (buffer a). The resultant protein 
solution was loaded onto a pre-equilibrated DEAE-Sephacel column. Protein was 
eluted with a linear gradient of 0-500mM NaCl in buffer a. Collected fractions 
showing DHQase activity were pooled and dialysed against 20 mM Tris/HCI buffer 
pH7.5 containing 0.4mM DTT (buffer b). The protein solution was loaded onto a 
Neobar-AQ column pre-equilibrated with buffer b and eluted with a linear gradient 
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of 0-25mM NaCl in buffer b. Fractions displaying DHQase activity were pooled and 
dialysed into 50mM potassium phoshate buffer pH 7.0 containing 1mM DTT. 
	
2.15 	Purification of the DHQase-like domain of QutR 
from A. nidulans. 
The DHQase domain of QutR was purified by Prof. A.R.Hawkins, University of 
Newcastle, using the following method [29]. 
The QUTR 3-dehydroquinate dehydratase-like domain was purified as a fusion 
protein with the 4.47 kDa metal chelating (MC) domain specified by plasmid 
pRSETB. The MC fusion protein was purified as previously described for the 
AROM 3-dehydroquinate dehydratase—MC fusion [103] with the following 
modifications; (a) the column containing the immobilized MC fusion protein was 
washed with 5 column volumes of buffer [103] containing 2.0 M glycine to remove 
nucleic acids and some contaminating proteins, and (b) the MC fusion protein was 
eluted from the column with a step gradient of 10 mM EDTA in buffer. The MC 
fusion protein was further purified to homogeneity by FPLC on a 4 ml NeoBar AQ4 
column (Flowgen) using an 80 ml linear 0.0-0.5 M NaCl gradient in 20 mM 
Tris/HCI, pH 7.2, following overnight dialysis in 20 mm Tris/HCI, pH 7.2. Fractions 
containing the desired protein were pooled and stored at 4 °C. 
2.16 	Purification of the Ala 143 mutant of E. coli type I 
dehydroquinase. 
Purification of mutant E. coli type I dehydroquinase was performed in the laboratory 
of Prof. John Coggins, University of Glasgow using the following method [119]. 
Crude cell extracts were subjected to ammonium sulphate precipitation with the 
precipitate formed at 75 % retained. The precipitate was dissolved in 50 mM 
Tris/HCI buffer pH 7.5 containing 0.4 mM DTT and 1.2 mM PMSF. The resulting 
protein solution was dialysed against 50 mM Tris/HCL buffer pH 7.5 containing 
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50mM KC1 (buffer a). The protein solution was loaded onto a DEAE-sephacel 
column pre-equilibrated with buffer and eluted with a linear gradient of 50-250 mM 
KC1 in buffer a. Fractions were pooled and dialysed into 25 mM Tris/HC1 buffer pH 
7.5 containing 0.4 mM DTT and 1.2 mM PMSF. The protein solution was 
concentrated and dialysed into 60mM potassium phosphate buffer pH 5.85 
containing 0.4 mM DTT and 1.2 mM PMSF (buffer b). The protein solution was 
loaded onto a hydroxyapatite column pre-equilibrated with buffer b and eluted with a 
linear gradient of 60-300 mM potassium phosphate buffer pH 8.5. Fractions were 
pooled and dialysed into 50 mM Tris/HCL ph 7.5 containing 0.4 mM DTT and 20 % 
glycerol. The resultant protein protein solution was loaded onto a Sephacryl S-200 
column pre-equilibrated with 50 mM Tris/HCL ph 7.5 containing 0.4 mM DTT and 
500 mM KC1. The protein was eluted with the same buffer before being dialysed 
into 20 mM Tris/HC1 ph 7.5 containing 0.4 mM DTT and 20 mM NaCl (buffer c). 
This was loaded onto a Mono Q column pre-equilibrated with buffer c and the 
protein was eluted in a 3 step gradient of 20 - 300 mM NaCl. Fractions showing 
dehydroquinase were pooled and dialysed into 50 mM Tris buffer ph 7.5 containing 
0.4 mM DTT and 1mM benzamidine. 
2.17 	Kinetic analysis of type I dehydroquinase. 
Type I DHQase follows Michaelis-Menten kinetics. And so calculations of kinetic 
parameters could be made using the equation; 
v= FS1.Vmax 
[S] + Km 
Where v = initial velocity, [S] = substrate concentration, Vmax = maximum velocity, Km = Michaelis 
constant [69] 
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Kinetic measurements were plotted using a Hanes plot (Figure 2.1). Kinetic 
measurements were taken spectrophotometrically by direct assay measuring of 
product (dhq) formation at either 234 or 240nrn [30]. Measurements were taken at 
various substrate (dhq) concentrations, using a constant amount of DHQase in 
100mM potassium phosphate buffer, pH7.0 in a final volume of irni. Enzyme 
concentration was 10 pM. 
V axis={S1/v 
X axis= [S] 
Figure 2.1. Schematic of a Hanes plot. 
Solutions were made up by serial dilution with potassium phosphate buffer by serial 
dilution and measurements were taken between 200 and 2 mM dhq. Measurements 
were taken at least in triplicate. Dhq concentration was established by either direct 
weighing of powdered dhq or by total conversion using the Beer-Lambert law [69]. 
Dehydroquinase converts dhq to dhs in a ratio of 15 to 1 [30]. Therefore using the 
equation; 
A=ECL 
Where A = final absorbance (absorbance units), E = molar extinction coefficient 
(moles/cm), C = concentration (moles/litre), L = path length (cm). 
Where the path length is a constant of 1cm and the molar extinction coefficient is 
known to be 1.2 x 104 moles/cm [30]. By allowing enzyme to completely convert 
dhq to dhs the initial concentration of dhq can therefore be calculated. 
	
2.18 	Kinetic analysis of putative inhibitors. 
Possible targets for competitive inhibitors were chosen for their chemical structure 
being similar to dehydroquinic acid. The main deciding factors being a six carbon 
ring and the presence of hydroxyl groups. These were purchased from either Sigma 
or Aldrich. 
10mM solutions of each chemical were made in 100mM potassium phosphate buffer 
pH 7.0. Kinetic measurements were taken in the same way for these solutions as for 
those of the previous section. 
Competitive inhibition is characterised by a change in Km with no change in Vmax. 
The Ki of any inhibitors can then be calculated by the equation; 
Kx = Km (1+ [I]/Ki) 
Where Kx = the new Km in the presence of inhibitor and [I] = Inhibitor 
concentration. 
2.19 	Borohydride reduction of type I Dehydroquinase. 
Borohydride reduction was performed using the method of Chaudhuri [35]. A 
solution of DHQase (0.5 mg/ml) in 50 mM potassium phosphate buffer, pH 7.5, 
containing 2mM substrate/inhibitor and 0.4 mM DTT in a total volume of 8 ml was 
treated with 3 sequential additions of 20 p.1 NaBH4 in 50mM NaOH. After each 








minutes. Enzyme activity was examined before NaBH4 addition and after the final 
addition and incubation stage. After successful reduction the protein was excessively 
dialysed into a solution of 20 mM phosphate buffer, pH 7.2, 1 mM DTT. 
2.20 	Crystallisation. 
All protein crystal lisations were performed by vapour diffusion, either by sitting or 
hanging drops [70]. These consisted of a small drop (between 2 and 20 tl) consisting 
of 50% protein solution of various protein / buffer concentrations at varying pH and 
50% well solution. The drop was either placed on a sitting drop bridge or hung from 
a siliconised coverslip (Figure 2.2). 
Silicon ised 
Figure 2.2. Set up of Sitting and hanging drops. Details are explained in text. 
Well solution was to a final volume of lml. This generally consisted of a buffer (of 
varying sort and at various pH) and a precipitant at varying concentrations (refer to 
results section for specifics of each crystallisation condition). 
The pH of each well solution buffer was generally of a 1M stock solution. In the case 
of Na cacodylate/ Ca acetate pH was of a 0.5M stock solution. Stocks were diluted 
in the well and so actual well pH is likely to be different to that stated. 
221 	Data collection and processing. 
For room temperature collection of diffraction data crystals were drawn into thin 
walled glass capillaries by capillary action. Excess mother liquor was removed with 
filter paper and well solution was drawn into the capillary to maintain equilibrium. 
Well solution was positioned away from the crystal. Capillaries were sealed with 
wax and positioned on goniorneter head with plasticene. 
For collection of diffraction data at 100 K crystals were transferred to a 
cryoprotectant solution and then mounted onto a suitable sized nylon cryo-loop 
(Hampton). Immediately after mounting the loop and crystal were plunged directly 
into liquid nitrogen before being transferred onto the goniometer which was in the 
flow of a nitrogen cryostream held at a fixed temperature at 100K. 
All diffraction data were collected on a FR59 1 rotating anode X-ray generator 
(Bruker-Nonius) with a Mar image plate detector. 
Diffraction data was indexed with the program MOSFLM [71, 72] and scaling of the 
resultant batch mtz files was performed by the program SCALA [72, 73]. 5% FreeR 
flags were added randomly using the program FreeR [72, 82]. 
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2.21 	Structure solution and refinement. 
Due to the different unit cells and spacegroups that crystals of type I dehydroquinase 
can form it is necessary to know the number of protein molecules in the asymmetric 
unit (A.U.). This was predicted using the Mathews coefficient [74]. 
When a crystal was found to be in a different unit cell structure solution was 
performed using the program MOLREP [75] using the original borohydride reduced 
structure (pdb code: I QFE [44]) as a search model. In all cases molecular 
replacement was immediately followed by 20 cycles of rigid body refinement using 
the program REFMAC 5.0 [76]. 
Full restrained refinement of each structure was performed using the program 
REFMAC 5.0 [76] and/or SHELX97 [77]. For ligands, restraints were produced 
automatically by the respective programs and then checked and corrected manually. 
NCS refinement was performed by the program REFMAC using each protein 
monomer in the asymmetric unit as an NCS unit. Simulated annealing was 
performed by the program CNS [78]. In cases of multiple occupancy values were 
obtained and refined using the program SHELX97 [77]. 
21F01 - FCI and IFol - FI maps were produced by the program FFT [79] and analysed 
manually using the program 0. Models were manually corrected also using 0 [80]. 
Waters were added automatically by the program Arp-Warp [81] and/or 
SHELXWAT [77]. All waters were checked manually in 0 for their positioning and 
fit to density. 
2.23 	 Structure analysis. 
Crystal contacts were analysed using the program Contact [72] and the model 
checked using the program PROCHECK [72]. All other aspects of the structures 
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were analysed manually. Final R and Rfree  values were produced using the program 
SFCHECK [72]. 
2.24 	 Figure production 
Except where otherwise stated all figures were produced using the program 




Production of active site mutants of type I 
dehydroquinase and their kinetic analysis. 
3.1 	Introduction. 
Chemical modification experiments have previously implicated four amino acids in 
the mechanism of type I dehydroquinase from E.coli [35]. Further mutagenesis 
experiments on the E. co/i enzyme confirmed the role of His 143 and Lys 170 as 
being integral to the mechanism of the enzyme [41]. Structural studies of the S. typhi 
enzyme have also confirmed the role of His 143 and Lys 170 in the enzyme 
mechanism [44]. From this structure His 143 appeared at too distant a position to act 
directly as the general base in the mechanism. The structure of the S. typhi enzyme 
also implicated Glu 86 as playing a role in the orientation of His 143 with Gly 87 
and Gly 88 implicated as adding flexibility to Glu 86. The loop that includes Glu 86 
could move in concert with His 143 therefore changing the flexibility of this loop 
might affect the enzymes rate in a subtle manner. 
To further test the importance of these residues attempts were made to mutate His 
143 to Ala, Glu 86 to Gin and Asp, Gly 87 to Pro and Gly 88 to Pro by PCR based 
site directed mutagenesis. 
Kinetic analysis of the resultant purified mutant enzymes was performed to analyse 
the importance of these residues in the mechanism. 
3.2 	Polymerase chain reaction. 
Site directed mutagenesis was performed utilising the polymerase chain reaction by 
the method of Hemsley [66]. Primers were designed as in figure 3.1 and reactions 
performed on previously produced plasmid pKK45 [83,120], which contained the 
AroD gene of S.typhi. 
1.. 
Eck to back primers with 
one encoding for desired mutant 
Primer number 
Wild type sequence 
5' CGC AGC GCC AAA CAA GGC GGC GAG CAG ACA ATA 3' Forward 
His 143 toAla 
5' GTG ATG TCT AAC CCC GAT TTT CAC CAG 3' - Forward primer 366 
5' GAC ATA AAC ATT ATG CGC ATG 3' -Reverse primer 	 367 
Glu 86 to Gin 
5' CGC AGC GCC AAA CAA GGC GGC GAG CAG 3' - Forward primer 368 
Glu 86 to Asp 
5' CGC AGC GCC AAA GPC GGC GGC GAG CAG 3' - Forward primer 369 
GLY 87 to AlA 
5' CGC AGC GCC AAA GAA CCC GGC GAG CAG ACA 3 '-Forward primer 370 
GLY 88 to AlA 
5' CGC AGC GCC AAA GAA GGC CCC GAG CAG ACA ATA 3' Forward 371 
Reverse primer forGiu 86, Asp 86,Gly 87 andGiy 88. 
5' GAA AGT AAA CAG TAA CGG AAT 3' 	 372 
Figure 3.1. Design of primers for the production of mutants. Points of mutation are coloured 
red. 
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Reactions worked using the same conditions for all five desired mutations, giving 
large bands of the correct size, as visualised by agarose gel electrophoresis (Figure 
3.2). 
1 2 3 456 
Figure 3.2. Results of polymerase chain reactions for each different mutation reaction. 
Lane 1 = ?,kb marker with sizes (top) 23130, 9416, 6557, 2322, 2027 (bottom) visible. 
Lane2 = Ala 87, lane 3 = Ala 88, lane 4 = GIn 86, lane 5 = Asp 86, lane6 = His 143. 
3.3 	Evidence for a mixed plasmid stock and for 
bacterial selectivity. 
Transformation of stock plasmid pKK45 into HBIOI and BL21 (DE3) bacteria 
revealed two different banding patterns and hence two different plasmids, suggesting 
that the stock plasmid may have been made up of more than one plasmid colony. 
Subsequent transformation of both purified plasmids into BL2 1 (DE3) and IPTG 
induction revealed that only the plasmid purified from BL21(DE3) was capable of 
protein over-expression, producing protein of the correct size for type I 
dehydroquinase, as visualised by SDS-PAGE. 
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Comparison of stock plasmid with these two different banding patterns revealed that 
pKK45 was identical to the inducible plasmid purified from BL2 1 (DE3). A banding 
pattern of the sort seen from HB1O1 could not be visualised in the stock plasmid 
suggesting that the large majority of the stock plasmid was made up of inducible 
plasmid (figure 3.3). 
1 23 4 5 6 
Figure 3.3. DNA agarose gel (left) and SDS-PAGE gel revealing different 2 different 
plasmids and their resulting expression. 
Lane 1= Wild type pKK45, 2= plasmid retrieved from H13101, 3= plasmid retrieved from 
BL21 (DE3), 4= induction of 2, 5= induction of 3, 6 = MW markers 29 kDa is marked by an 
arrow. 
In all cases where plasmid stock pKK45 was transformed into HB 101 non-inducible 
plasmid was obtained on purification indicating that HB1OI was selective against 
the inducible plasmid. Transformation of purified inducible plasmid into HB 101 
resulted in inducible plasmid being produced by HBIO1. Subsequently the AroD 
autosomal E.coli line 5K3430 was used for subsequent transformation of ligation 
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product. Inducible plasmid purified from BL21 (DE3) (designated pKK68) was 
subsequently used for all polymerase chain reactions. 
	
3.4 	Sequencing of pKK68 revealed errors in published 
AroD sequence. 
To confirm the identity of pKK68 as AroD its DNA was sequenced (sequencing 
performed by University of Newcastle sequencing unit). Sequencing revealed 3 
differences when compared to the original published sequence. Position 458 showed 
a change from C to T but this did not translate to a change in amino acid sequence. 
Position 567 and 568 showed a TC to CT change and on translation would cause a 
change from Serine 156 to Leucine 156. This amino acid change had previously 
been indicated from electron density in the original structure of S.typhi type I 
dehydroquinase (L. Sawyer personal communication). 
3.5 	Production and purification of mutants. 
Production of the GIn 86 and Asp 86 mutants was achieved from the same primers 
for both mutants. The mutagenic primer used was primer 368 which is Gin 86 
specific but due to a PCR artefact the Asp 86 mutant was also produced in the same 
set of PCRs. The sequences for both these mutants show no other differences to the 
sequence for pKK68. 
Production of the Pro 87 and Pro 88 mutants was achieved using their specific 
mutagenic primers. Pro 87 sequence analysis showed no differences to the pKK68 
sequence other than those translating to the mutation. The Pro 88 mutant sequence in 
addition to the desired mutation contained a single point mutation at position 139 (T 
MV 
to Q. This mutation is redundant as it does not translate to an amino acid change in 
the final protein. This mutant plasmid was therefore still used for protein production. 
Production of the Ala 143 mutant was unsuccessful as no plasmid products 
contained the desired mutant sequence. 
Growth and purification of mutant protein was performed by Prof. A. Hawkins. The 
wild type, Gln 86 and Asp 86 mutant proteins were found to be soluble and purified 
to greater than 95 % homogeneity (Figure 3.4). The protein for the Pro 87 and Pro 
88 mutants was found to be insoluble and so was not purified. 
27kDa 
M I\Mt IJcr 
Figure 3.4. Examples of purified protein for mutant and wild type dehydroquinase from S. 
typhi 
3.7 	Discussion. 
It is not known what the contamination of plasmid pKK45 was or where it 
originated although it is obvious that it inhibited the production of mutant plasmid 
and their resultant purification. Due to beginning with the HB101 cell line a great 
deal of time was used before identifying and resolving the problem. The selectivity 
for this plasmid in 1-113101 cells was most likely due to the inhibitory effect to 
growth of overproducing the type I enzyme. This was not so apparent in BL21 
(DE3) cells and even less apparent in SK3430 cells resulting in the subsequent use 
of both of these cell lines and not HB1O1 cells. 
The reason for not producing the Ala 143 mutant is not clear and may be due to 
primer design and or the PCR conditions used, although this was not evident in 
agarose gels. An Ala 143 mutant is available for the E. coli enzyme and this could 
be used for studying the effect of this mutation on the enzyme. The S. typhi and E. 
coli enzymes are highly similar and so direct comparisons could be made. 
The reason for the insolubility of the Pro 87 and Pro 88 mutants is also unclear but 
may be due to a stiffening effect that the glycine to proline change has on this loop 
and could not be predicted. As there is a straightforward assay for the activity of 
DHQase attempts could be made to unfold and refold the protein in a soluble state 
(ie; with urea). The activity of the enzyme should return with correct folding and 
could be traced with the kinetic assay. 
The kinetic characteristics of the wild type enzyme are similar to those published 
[30]. The kinetic results for both mutations are similar and show a small but 
significant difference to that of the wild type, indicating that these mutations affect 
activity. The similarity of both mutants and the relatively small size of the difference 
to the wild type would suggest that this effect is a subtle rather than a dramatic one. 
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Chapter 4 




Structural studies have previously been performed on Type I dehydroquinases from 
both E. co/i and S. typhi and the structures of both enzymes solved [44, 46, (E.coli 
structure unpublished]. These structures were solved utilising the technique of x-ray 
crystallography. To analyse further the importance of active site residues structural 
studies of type I dehydroquinase from S. typhi and E. co/i were undertaken. These 
studies also utilised x-ray crystallography. 
4.2 	Crystallisation of type I dehydroquinase from S. 
typhi. 
The first stage and generally the rate limiting step of x-ray crystallography is the 
production of high quality crystals that are capable of the ordered diffraction of x-
rays. 
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3.6 	Kinetic characterisation of type I dehydroquinase. 
Type I dehydroquinase follows Michaelis-Menten kinetics and analysis of wild type 
and mutant enzyme was perfornied by direct assay. Results are shown in table 3.!. 
Wild type Gin 86 mutant Asp 86 mutant 
Km(tM) 16.95 +/- 2 14.56 +/- I 15.0+-I 
(sd ) 153 +1- 10 0/> 70+1-5% 76+1-5% 
k > /Kni 	(s' 
M') 
9 x lOô 4 X 105 x106 
Table 3.1. Kinetic results for wild type and mutant type I enzymes. Errors are calculated 





Figure 3.5. Hanes plot of kinetic results for wild type and mutant type I enzymes. Blue points 
/ line = wild type, Yellow = Asp 86 mutant enzyme, Pink = Gin 86 mutant enzyme. ([S] = dhq 
concentration 1iM v= Absorbance Units / S1). 
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The basic principles of protein crystallisation are the same in most respects as those 
that form the foundation for the more familiar techniques of crystallising small 
molecules such as salts or amino acids. 
To grow crystals of any compound, molecules must be brought to a supersaturated, 
thermodynamically unstable state, which may result in a crystalline or amorphous 
phase when it returns to equilibrium. This supersaturated state may be achieved by 
the slow evaporation of solvent or by varying some or all of the parameters in a 
closed system. In such conditions of low solubility, appropriate molecular aggregates 
slowly reach a critical size or nucleus from which the growth of the macroscopic 














Figure 4.1. The operational principles of vapour diffusion and batch techniques, in terms of 
supersaturation levels. Line A corresponds to the vapour diffusion technique where through 
a decrease in drop volume causes an increase in protein and precipitant concentration. 
Saturation is moved into the labile zone where nucleation occurs and due to some protein 
no longer being in solution saturation is moved into the metastable zone where crystal 
growth may occur. Line B corresponds to the batch technique. Protein and precipitant 
concentration starts in labile zone hence nucleation is starting point and like in A the 
nucleation causes protein concentration to decrease into the metastable zone allowing 
crystal growth. 
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In this project crystallisation was performed utilising the hanging drop method. In 
the case of type I dehydroquinase from both S. tvphi and E. co/i crystallisation 
conditions had already been established prior to the start of this project [42]. 
Attempts to reproduce the conditions of Boys et a! [42] for the S. typhi enzyme 
failed to produce crystals of diffraction quality (Figure 4.2). 
pppwft-'~ 4 01mm 
I 
Figure 4.2. Crystals formed using the conditions of Boys et a! [42]. Crystals formed at best 
large masses of poorly formed needles. 
A number of crystal screens were set up to establish new crystallisation conditions. 
Solution 20, 0.2M Ca acetate hydrate, 0.1M Na cacodylate pH 6.5, 18% wlv PEG 
8000 from Structure Screen I (Molecular Dimensions Ltd) resulted in a large 
number of small (less than 0.2mm longest dimension) poorly formed crystals. 
Subsequent refinement of these conditions to 0.1 M Ca acetate, 0.05M Na cacodylate 
pH 6.0, 11% PEG 8000 resulted in large crystals (greater than 1mm largest 
dimension) of various forms. In all cases protein solution was 10 mg/ml in 20 mM 
phosphate buffer pH 7.2, 1 mM DTT (figure 4.3). Under these conditions immediate 
precipitation was apparent on mixing protein and well solutions. This precipitate was 
likely Ca phosphate and on occasion made crystals hard to visualise or manipulate. 
Removal of either phosphate or Ca acetate from the crystallisation conditions did not 
result in crystals however and so was necessary. 
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Figure 4.3. 	Crystals from initial and refined crystallisation conditions of type I 
dehydroquinase from S. typhi. Image 1 is of original crystals found from screen conditions. 
Images 2, 3 and 4 are of crystals formed from refined crystallisation conditions (See text.). 
4.3 	Crystallisation of type I dehydroquinase from E. 
COIL 
Crystals of Ala 143 mutant E. co/i type I dehydroquinase could be obtained using the 
same conditions as those used for the S. tvphi enzyme. These crystals took the form 
of poorly formed thin plates and were not of good enough quality to be used for 
diffraction studies. 
Crystals were found to grow in a number of different conditions. The largest crystals 




(protein concentration), 20mM phosphate buffer pH 7.2, 5mM DTT (protein 
solution). These crystals were also found to be primarily large plates (Figure 4.4). 
Figure 4.4. Crystals of type I dehydroquinase from E. co/i. No difference was apparent 
between crystals produced from protein to which dhs was irreversibly bound after 
borohydride reduction and those co-crystallised with dehydroquinate. 
4.4 	Diffraction of type I dehydroquinase from S. typhi. 
Initial diffraction tests were performed at room temperature in order to establish a 
baseline to see the effect of cryo-freezing on crystal quality. Crystals were capable of 
diffraction to better than 2 A. Diffraction showed a particular form of disorder where 











Alternate rows show streaking of reflections. 
Figure 4.5. Diffraction of type I dehydroquinase from S. typhi showing streaking of every 
alternate row of spots. 
Subsequent analysis of these crystals by the rotations of 90° revealed that diffraction 
down the crystals long axis was streaked in alternate lunes whilst down the shortest 






Figure 4.6. Analysis of streaky diffraction from a single crystal. 
Diffraction patterns shown are taken from a single crystal of type I dehydroquinase from S. 
typhi shown in A. Crystal was exposed in three directions each 900  from the other, shown 
schematically in B. Directions correspond to direction through A which is in approximate 
alignment to B. Diffraction patterns for each direction through the crystal are at the end of 
each red arrow. 
Diffraction pattern C shows streaking of reflections in every alternate column. Image is close 
to a crystallographic axis indicated by the presence of a principal zone. Diffraction pattern D 
shows no streaking and there is no indication of a principal zone. Diffraction pattern E also 
shows the presence of a principal zone but in this case streaking is apparent in all 
reflections in every alternate lune. 
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This streaking was found to be removed by the increase of dithiothreitol (DTT) to 
5mM in crystallisation drops. Subsequent room temperature diffraction patterns 
showed no sign of this streaking pattern. In some older crystals grown in 5mM DTT 
there is some evidence of a return of this streaking (Figure 4.7). Addition of further 
DTT to crystals expressing this streaking did not result in improved diffraction. 
Figure 4.7. Diffraction of type I dehydroquinase crystal grown in the presence of 5mM DTT 
(image 1). Diffraction of 3 month old crystal of type I dehydroquinase grown in the presence 
of 5 mM DTT. Diffraction shows return of disorder in every alternate row. Every disordered 
row contains double the amount of reflections (image 2). 
4.5 	Diffraction of type I dehydroquinase from E. coil. 
Crystals of the Ala 143 mutant E. co/i type I dehydroquinase grown in the presence 
or absence of dehydroquinate diffracted very weakly at room temperature. 
Diffraction was ordered in one direction of the crystal but rotation of the crystal by 
900 showed disorder. Due to the plate like nature of these crystals it was not possible 
to perform a more complete analysis of this disordering. 
Attempts to remove this disordering with the refinement of crystallisation conditions 
failed to achieve better crystals. Although DTT was tried it was not found to have 
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the same effect on the E.coli enzyme as it had on the S.typhi enzyme and failed to 
remove the disordering. 
iC 
Figure 4.8. Diffraction of type I dehydroquinase from E. coil. Image 1 shows that diffraction 
in one direction of the crystal is well ordered. Image 2 is an image of the same crystal 
rotated 900  and shows disorder of the crystal in this direction. The obvious fibre diffraction 
spots arise from the cryo-loop. 
4.6 	Crystal soaking and co-crystallisation of type I 
dehydroquinase. 
In order to understand any changes that may occur to type I dehydroquinase during 
its catalysis of the dhq to As reaction it was necessary to attempt the elucidation of 
structures both with and without product / substrate in the active site. Previous to the 
undertaking of this project structures of the wild type S.typhi enzyme containing dhs 
borohydride reduced to Lys 170 had been solved. This method effectively 
inactivated the enzyme and the structures posed questions regarding the orientation 
of dhs and the imine bond to Lys 170. To further understand this it was necessary to 
obtain crystals of active dehydroquinase containing dhs in the active site that was not 
covalently linked to lysine 170. 
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Protein-ligand complexes can be obtained either by co-crystallising directly from 
solution or by the soaking of ligand directly into pre-formed crystals. Soaking of 
crystals is made possible by protein crystals containing channels of a large enough 
size to allow the diffusion of small molecules throughout the lattice, a fact that heavy 
atom replacement relies upon. As well as heavy atoms, however, in some cases it is 
also possible to soak small molecules such as ligands or substrates into the protein 
itself. This is may be inhibited by the size of the molecule and by the crystalline 
lattice. 
Attempts were made to soak dhq directly into crystals of type I dehydroquinase from 
S. typhi by the addition of various concentrations of dhq to crystallisation drops in 
which crystals of dehydroquinase had already grown. Although in most cases 
crystals appeared to survive this process analysis of their subsequent diffraction 
patterns showed various degrees of general disorder. 
Due to this disordering co-crystallisation was attempted. The same crystallisation 
conditions for native dehydroquinase were used with between 10 and 15 mM dhq 
present in the protein solution. Under these conditions it was found that crystals 
grew normally. Subsequent analysis of the diffraction of these crystals showed no 
disordering. 
4.7 	Cryo-crystallography and type I dehydroquinases. 
Cryo-crystallography is a technique that allows x-ray data collection to be performed 
at lOOK as opposed to room temperature. The main motivation behind this is the 
observation that radiation damage to protein crystals is greatly reduced at lower than 
room temperatures. Radiation can be a major and limiting problem at room 
temperature as it can cause at the very least a decrease in diffraction resolution and 
eventually destruction of the crystal. Haas and Rossmann (Figure 4.9) first made this 
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observation in 1970 [84] but it was not until the 1990's that general techniques for 
the freezing of crystals were established [85]. 
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Figure 4.9. Analysis of temperature on diffraction intensity. 
The ratio of / / I plotted as a function of exposure time for two reference reflections 
measures on two typical crystals of lactate dehydrogenase at 28 and 198 K. I and I 
represent the intensity at times t = 0 and t = t respectively. (Taken from Garman and 
Schneider [86]). 
The primary cause of this radiation damage is through absorption of the direct beam 
thus providing the energy needed to break bonds. Two major mechanisms exist for 
the production of reactive radicals. The first of these is direct, through damage to the 
polypeptide, whilst the second is indirect by the production of reactive 1-F and 0H 
from water molecule destruction. Thermal energy allows the diffusion of these 
reactive radicals throughout the crystal which in turn cause secondary damage. The 
extent of this secondary radiation damage is dependent on both time and temperature 






Figure 4.10. Schematic diagram of radiation damage through a crystal. For a full 
explanation see body text. 
With time at room temperature, these reactive products are able to diffuse throughout 
the crystal and in combination with the dose dependant primary damage can often 
destroy the crystal. Freezing of crystals in liquid nitrogen effectively immobilises 
these reactive products and consequently they do not cause extensive secondary 
radiation damage to those regions of the crystal not directly exposed to the x-ray 
beam. 
Protein crystals generally have high water content (approximately 50%) and 
subsequently they require special treatment to freeze them successfully to cryo-
temperatures. This is to avoid the production of ice micro-crystals that may both 
damage the protein crystal lattice and cause ice diffraction rings to spoil the data. 
These rings may inhibit the taking of complete data sets. Consequently crystals must 
be either grown in or transferred into a suitable cryo-protectant solution in which the 
crystals are stable and are not significantly damaged by transferral into such a 
solution. 
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Attempts to grow crystals of type I dehydroquinase from S. typhi in a cryo-protectant 
solution failed to produce any crystals and consequently either crystals had to be 
transferred directly into cryo-protectant solution or the crystallisation drops had to be 
altered to cryo-protectant conditions either by the addition of cryo-protectant directly 
to the drop or by the adjusting of the well solution. 
Despite large numbers of trials with various cryo-protectants such as glycerol, PEG, 
MPD and oil no crystals were ever successfully frozen by direct transfer of crystals 
into cryo-protectant. Adjustments to both the time crystals were soaked for and the 
size of each cryo-protectant concentration step did not significantly improve freezing 
and all crystals frozen in this manner showed varying degrees of disorder in their 
diffraction patterns. Similarly with alterations to well solution (slowly increasing 
PEG 8000 concentration to 45%) very few crystals were successfully frozen. 
Crystals treated in this way also showed disorder in their diffraction patterns, 
although this was in general less than that seen with direct transfer of crystals into 
cryo-protectant solutions. Using this method a number of crystals were lost in 
crystallisation drops of small volumes due to the decrease in the drop volume as 
PEG 8000 concentration was increased. 
Very few crystals were successfully frozen to the extent where structure solution was 
possible. One crystal was frozen by the direct transferral of 70% w/v PEG 4000 to 
crystallisation drops in a step-wise manner. After each addition of PEG 4000 
crystallisation drops were replaced over well solution and allowed to re-equilibrate. 
PEG 4000 concentrations of between 35 and 40% w/v were able to confer cryo-
protection to crystals. Although this crystal was successfully frozen in this manner, 
this crystal represents less than 5% of the crystals screened for diffraction after 
treatment in this way. All other crystals showed disorder in their diffraction patterns 
and subsequently were not used for data collection (Figure 4.11). Other crystals that 
were successfully frozen were transferred to cry-protectant conditions by the placing 
of the coverslip holding the hanging drop in which crystals had grown over a well 
containing 50% MPEG 5000 and allowing the drop to equilibrate for 48 hours. After 
this time crystals could be removed and plunged directly into nitrogen. This was by 
far the most successful method of freezing although a large number of crystals were 
still highly disordered and no data could be collected from them. 
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Figure 4.11. Diffraction of S. typhi type I dehydroquinase crystals frozen to 100K. Image 1 
shows diffraction of crystals frozen by direct transfer into cryo-protectant. Image 2 shows 
diffraction of a crystal frozen by increasing PEG 8000 concentration to 45% in the well 
solution. 
Due to the inability of crystals of S. typhi type I dehydroquinase to be consistently 
frozen the majority of data set collections were performed at room temperature. 
4.8 	Discussion. 
Despite the inability to repeat the crystallisation conditions of Boys et a! for S.typhi 
dehydroquinase, crystals were eventually grown and the subsequent refinement of 
conditions to obtain larger crystals was reasonably straightforward. Obtaining 
crystals that were capable of the ordered diffraction of x-rays was not so 
straightforward and was the rate-limiting step with regards to structure solution of 
this project. The exact nature of the effect DTT has on these crystals is unclear. Boys 
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et al stated that 1 mM DTT was necessary in crystallisation drops under their 
conditions, stating that it was necessary for the stabilisation of crystals. An 
explanation for what DTT was doing was not given [42]. 
DTT is a well established reducing agent and in proteins is known to reduce 
disulphide bonds that forrn between cysteine residues. Type I dehydroquinase from 
S. typhi does not contain any cysteine residues and so evidently this cannot therefore 
be the effect that DTT is having on the enzyme and its crystallisation. It would 
therefore seem likely that DTT is involved either directly in the packing of the 
crystal or is having some other effect on the protein that stabilises crystal packing. 
The particular form of disorder found in S. typhi enzyme crystals is indicative of a 
disordering in only one crystal plane. The alternate streaking of columns of 
reflections is similar to a pattern shown in the atlas of optical transforms [88]. 
However there they are describing a disordering resulting in a change of cubic to 
hexagonal unit cells. This is obviously not what is occurring here. Indexing of 
diffraction images reveals that two possible unit cells seem likely and suggests 
disordering results in a change from a primitive monoclinic unit cell to a C centred 
monoclinic cell. Although reflection predictions for either of these unit cells fail to 
cover all reflections and so are not completely correct. 
Analysis of 900  rotation of crystals which gave these streaking patterns confirms 
these crystals as being monoclinic by the presence of two principal zones 
approximately 90° apart. These rotated images also suggest of sliding in only one 
direction of these crystals with the disorder occurring along the long axis of the 
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Figure 4.12. Schematic of crystal giving a streaked diffraction pattern. Dashed arrows and 
boxes indicate crystal planes and the direction of their disorder. Red arrows indicate 
direction of x-rays and the type of image gained in each direction. 
Due to the plate like quality and the weak diffraction of E.coli crystals analysis such 
as that performed on the S.typhi enzyme could not be performed. It does appear that 
these crystals also have a sliding disorder due to them having good diffraction in one 
crystal direction. The crystal structure of the E.coli enzyme has been solved with X-
ray data from a solitary crystal and the crystal packing of this structure does suggest 
a weakness in the crystal packing which may be the site of this disordering (Figure 
4.13). 
Figure 4.13. Schematic showing the crystal packing in the E.coIi type I dehydroquinase 
structure. Yellow lines indicate protein backbone atoms. (Picture courtesy of D. Cronin) 
Attempts to soak S.Iyphi crystals with dhq resulted in disordering of the diffraction 
pattern. A reason for this is suggested by the crystal packing of previously solved 
structures. When the structure containing the covalent intermediate (trapped by 
borohydride) is compared to the native structure, the movement of a flexible loop is 
seen to be involved in substrate binding. The loop is seen to trap the substrate and in 
the absence of substrate is open and extended (Figure 4.14). 
2. 
Figure 4.14. Schematic showing the movement of loop (red circle) in the native and 
substrate bound forms. Image 1 is of the native enzyme and image 2 is of the substrate 
bound enzyme. 
The packing of the S.Iyphi dehydroquinase monomers in the native structure 
indicates the proximity of these loops to neighbouring molecules. This packing 
arrangement results in the restriction of the loop's movement in the crystals. 
Therefore when crystals are soaked with dhq the closing of this loop results in the 
breaking of crystal contacts and the disordering of the crystals (Figure 4.15). 
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Figure 4.15. Schematic showing the crystal packing in the native form of type I 
dehydroquinase from S.typhi. Yellow lines indicate protein backbone atoms. Red indicates 
moveable loop. 
The movement of this loop and relationship to packing may also be the reason for 
the difficulties in freezing crystals of the S.typhi enzyme. Changes to equilibrium 
may cause this loop to move and so perturb any packing interactions. 
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Chapter 5. 
Structural solutions of wild-type type I 
dehydroquinase from S. typhi. 
5.1 	Introduction. 
Prior to the starting of this project a total of three crystal structures of type I 
dehydroquinase from S. typhi had been solved [44, 46]. Two of these structures had 
the reaction product covalently bound to them by treatment with sodium borohydride 
whilst the third crystal structure was of the native form of the enzyme. These three 
crystal structures all showed different packing with the native crystal structure being 
in spacegroup P21 21 2. The two crystal structures containing covalently bound 
product were both found to be in the P21 spacegroup but with different unit cells. 
To further analyse both the wild type enzyme's mechanism and its crystal packing 
crystals were grown containing the product covalently bound to lysine 170. Co-
crystals were grown of wild type enzyme and substrate and native enzyme crystals 
were also grown. 
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5.2 	Structures of borohydride reduced wild type type! 
dehydroquinase from S. typhi. 
Two structures of wild type dehydroquinase were solved with the product (dhs) 
covalently bound to lysine 170 by borohydride reduction. (Structures designated 
KK68nabh_pll and KK68_nabh_pl_2.) 








Unit Cell a,b,c 	(a,13,y 	) 43.39,46.02,79.6 
(95.99, 97.78, 	118.22) 
Collection Temperature room temperature 
Data Range A (High shell) 13-2.25 	(2.37-2.25) 
R sym % (High shell) 8.3 (20.6) 
Completeness (highshell) 91.2% 	(91.2%) 
i/si (high shell) 6.1 (3.2) 
Multiplicity (high shell) 1.7 	(1.7) 
unique reflections 25123 
Number of protein 
monomers in A.0 2 
Matthews Coeff 2.5 A3  
% solvent 49.9% 
P1 
42.69, 79.51, 80.88 









2.3 A3  
46.8% 
Table 5.1. 	Processing statistics for crystals KK68_nabh_pl_1 and KK68_nabh_pl_2. 
Due to these structures being in two new packing forms molecular replacement was 
performed to solve these two structures, using the program MOLREP [75]. 
Molecular replacement results are shown in table 5.2. 
In both cases the dimer form of the original published structure (pdb code; 1QFE 
[44]) was used as the search model. The asymmetric unit of KK68 nabhp 1_2 was 
found to contain two dimers in the asymmetric unit and so a dyad search was 
performed. 
72 
Solution of kk68_nahh4,,pIj 
first 5 rotation function peaks; 
#Sol 	alpha beta gamma theta phi chi 	Rf 	Rf/sigm 
SolRF 1 	97.25 143.78 145.10 105.63 -113.93 161.48 0.1274E+05 24.32 
S01RF 2 264.25 	36.21 324.26 160.27 	60.00 134.03 	0.12705+05 24.25 
S01RF 3 304.91 80.30 202.96 41.28 -39.03 155.57 2675. 	5.11 
S01RF 4 	121.85 	92.89 255.85 	81.68 -157.00 	94.18 	2673. 5.10 
first 5 translation function peaks; 
alpha beta gamma Xfrac Yfrac Zfrac Dens/sig R-fac Corr 
Sol TF1 1 	97.25 143.78 145.10 0.000 97.247 143.777 	24.32 0.385 0.641 
Sol_TF_2 1 84.25 -36.21 144.26 1.000 97.247 143.777 24.32 0.376 0.659 
SolTF_3 1 124.91 -80.30 	22.96 1.000 97.247 143.777 	24.32 0.584 0.147 
SolTF_4 1 121.85 	92.89 -104.15 1.000 97.247 143.777 24.32 0.586 0.142 
S01TF5 1 	17.41 94.88 -82.93 1.000 97.247 143.777 	24.32 0.588 0.139 
solution used; 
Sol Mon 1 Rf-2 Tf 1 	264.25 	36.21 324.26 0.000 0.000 0.000 0.376 0.659 
solution of kk68_nabh4pl_2 
first 5 rotation function peaks; 
#Sol_ 	alpha beta gamma theta phi 	chi 	Rf 	Rf/sigma 
So1RF 1 84.94 35.18 324.78 37.02 150.08 60.25 0.2370E+06 25.01 
So1RF 2 277.88 144.75 144.69 80.63 -23.41 150.01 0.2349E+06 24.80 
Sol_RF 3 235.01 155.08 212.42 81.32 -78.71 162.06 0.4282E+05 	4.52 
So1RF 4 	133.66 	44.09 288.11 	38.27 -167.22 	74.61 0.42285+05 4.46 
first 5 peaks found in dyad search; 
Sol_ 	Ri R2 Rs Rslf STF TF 	Shift 1 	PFxnax PFmin Rfac 	Corr 
Sol_ 1 	1 	1 	0 	1 	1 0.000 0.000 0.000 1.01 -1.00 	0.644 0.573 
Sol_ 	1 2 1 0 1 1 0.000 0.000 0.000 1.01 -0.97 0.428 0.680 
Sol_ 1 	3 	1 	0 	4 	1 0.000 0.000 0.000 1.00 0.14 	0.658 0.203 
Sol 	1 4 1 0 1 1 0.000 0.000 0.000 1.00 0.04 0.653 0.215 
501 1 	5 	1 	0 	3 	1 0.000 0.000 0.000 1.00 0.13 	0.657 0.205 
solution used; 
Sol 	1 	2 	1 	0 	1 	1 0,000 0.000 0,000 1.01 -0.97 	0.428 0.680 
Table 5.2 	Molecular replacement solutions for crystals KK68_nabhp1_1 and 
KK68nabh_p1_2. (Tables produced as part of the output for the program MOLREP [75]). 
Refinement solutions for structures KK68nabLpl_1 and KK68_nabh_pl_2 are 
shown in table 5.3. 
Crystal 	 KK68_nabh4_pl_1 	 KK68_nabh4_pI_2 
Refinement. 
Resolution range (A) 	 13 - 2.25 	 29.88 - 1.56 
Reflections used (Rfreeset) 21765 (1158) 	 88645 (4714) 
Rcryst (Rfree) % 	 19.51 (29.51) 	 18.12 (21.98) 
r.m.s.d bond lengths/Angles 	0.04/0.019 	 0.020/1.806 
Average B main/side chain 	20.49/25.12 	 16.48/19.49 
Table 5.3. Refinement statistics for structures KK68_nabh_pl_1 and KK68_nabhpl_2. 
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5.2.1 	All reduced structures show near identical folds to 
the original. 
Overlaying of all six new dirners with that of the original P21 borohydride reduced 
structure reveals that the overall fold of each structure is identical with very little 
movement either internally in each monomer or externally between monomers that 
make up each dimer. No significant hinge movement is apparent in the dimer (Figure 
5.1). 
Figure 5.1. 	Overlay of the four borohydride reduced dimers solved to date. Each dimer 
is coloured differently. Average RMSD for all main chain XYZ positions = 0.58 A. 
Only one small difference is apparent in positioning of backbone atoms between 
these structures. Structure KK68p12 shows a flipping of alanine 196 giving a cis 
peptide bond but no significance for this is evident (Figure 5.2). This is possibly due 
to an error in the original published structure or may be a genuine variation caused 
by the freezing of this crystal. 
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Figure 5.2. 	Overlay of a monomer from the published borohydride reduced structure 
and a monomer from KK68_pl_2. The difference caused by Ala 196 flipping is circled in 
green (image A). Close up of this flipping and the electron density for KK68_pl_2 is shown 
in image B. Electron density is of a 2IF0I-IF map (produced using FFT [79]) and is 
contoured at 1 sigma. 
5.2.2. 	The Hh loop is closed and well defined in density. 
As with the original structure the Hh loop takes the closed form in both of these 
structures and is well defined in density (Figure 5.3). In both structures residue 236 








Pro 234 	• -. 	 lie 237 
Figure 5.3. 	Electron density of the Hh loop for the KK68_pl_1 (left image) and 
KK68_pl_2 (right image) structures. Both structures are shown in the same orientation. 
Electron density is of a 21F.1-IFI  map (produced using FFT [79]) and is contoured at 1 
sigma. 
5.2.3 	Comparison of active sites. 
In both structures the density of the active site region in all monomers is excellent 
(Figure 5.4) allowing accurate positioning of both the product and all residues. This 
was made particularly easy by the high resolution ofKK68_nabpl_2. 
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Figure 54. 	Stereo diagram of the active site of KK68_nabh_pl_2. Electron density is of 
a 21F01-IFJ map (produced using FFT [79]) and is contoured at 1 sigma. 
Overlaying the active sites of each monomer including the original published 
structure revealed little to no difference in the positioning of active site residues or of 
the covalently bound product (Figure 5.5). 
The relationship between His 143, Lys 170, Glu 86 and the product was near 
identical in all cases and no significant movement was apparent. 
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Figure 5.5. 	Overlay of all NaBH4 reduced structure active sites. (Image produced using 
the program 0 [80]. Average XYZ RMSD for all active site side chain atoms = 0.15 A. 
The main difference between the original published structure and the new structures 
discussed here with regards to the active site residues is the presence of water 
binding to Glu 86. In the original published structure two water molecules were 
present binding to the 0E2 oxygen of Glu 86 in the A chain whilst only one was 
present binding to this atom in the B chain. 
In the active sites discussed here five of the Glu 86 0E2 atoms were bound to three 
water molecules (Figure 5.6) whilst the sixth (KK68nabhpl_l chain A) was 
bound to only one. The significance of this is unclear and may be a crystallisation 
artefact although these may strengthen the position of His 143 by Glu 86. 
in 
Figure 5.6 Electron density of Glu 86 from chain A of KK68_nabh_pl_1. Hydrogen bonds 
are denoted by red lines. . Electron density is of a 2IF0I-IFI map (produced using FF1 [79]) 
and is contoured at 1 sigma. 
5.2.4 	KK68_nabh_pl_2 is binding sodium. 
The high resolution of the KK68 nabh_pl_2 structure indicated a possible metal 
ligand binding to the carbonyl oxygen of Thr 148. This was most obvious in the D 
chain in the asymmetric unit where six other atoms appeared to be binding to a 
central atom at distances between 2.2 and 2.4 Angstroms. These distances are within 
the recognised distances for the metals calcium or sodium when binding to water and 
the carbonyl oxygen of threonine. Both these metals were present in crystallisation 
drops and it was therefore feasible that either metal could be in this position. Also 
present in crystallisation drops was potassium. Potassium has shorter binding 
distances than those observed in this structure and so could be discounted. 
Differences with refining these positions for either sodium or calcium were 
inconclusive and gave no indication as to which metal was in these positions. 
Although the difference in electron composition between Na and Ca is such that after 
refinement with each metal analysis of IF,,I-lFc l difference electron density should 
give an indication as to which metal is correct, this was inconclusive. Analysis of the 
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Na + 1-1,0 
L 
Thr 
pdb database (M.Harding personal communication [89]) gave only two precedents 
(one for calcium and one for sodium) for sodium or calcium metals exhibiting the 
geometry seen for the metal by threonine D 148 (pdb codes 1DMU, !UDB [90, 91]). 
It was therefore decided to leave the metal in this position as a sodium (Figure 5.7) 
as in the crystallisation drops it is likely that a large amount of the calcium is made 
unavailable by its precipitation with phosphate. The size of resultant electron density 
for sodium was concerning due to its similarity in size to the surrounding waters. 
Due to the large size of sodium it could be expected to exhibit larger density. There 
are other precedents of sodium co-ordinating water in which all atoms appear a 
similar size [92]. 
The other chains also contained atoms binding to the carbonyl group of Thr 148 and 
in two of these; five water molecules were bound to a central metal. Both of these 
metals were also left as sodium. In chain A the atom binding to Thr 148 was only co-
ordinating with two other atoms and the distances were too long to be from calcium 
or sodium and so this atom was left as a water. 
Figure 5.7. 	Stereo picture of threonine D 148 binding to sodium which is co-ordinating 
six further waters. . Electron density is of a 2IF0I-I17! map (produced using FFT [791) and is 
contoured at 1 sigma. 
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5.2.5 	KK68_nabh_pl_2 contains disordering of specific 
methionine residues. 
On full analysis of electron density of all residues of the KK68_nabh_pl_2 structure 
it was evident that the side chains of methionines 15 in the A and C chains and the 
side chains of methionines 247 in the B and C chains were in two distinct positions. 
As evidenced by the presence of IF0I-IFI density peaks (Figure 5.8). Occupancy 
refinement of these residues revealed that no connection between the positions of 
these methionines (Occupancy values are given in table 5.3). No mechanistic or 
significant structural relevance could be found for these alternate positions. This is 
possibly a general feature of these methionines in type I dehydroquinase from 
S.typhi. Methionines are capable of large movements and so can be in a number of 
different positions. These methionines are not found binding to other residues and so 
are not restricted in their positioning therefore they can take a number of different 
conformations. The high resolution of the KK68_nabhpl_2 structure allows this to 
be identified and refined. 
Residue Position A occupancy Position B occupancy 
MethionineA 15 0.332 0.668 
Methionine B 247 0.493 0.507 
Methionine C 15 0.598 0.402 
Methionine D 247 0.616 0.384 








Figure 5.8. Stereo picture of residues 244 to 250 from the B chain of the KK68_nabh_pl_2 
structure. Both positions of Met 247 are shown. Electron density is of a 21F01-lFI map 
(produced using FFT [79]) and is contoured at 1 sigma. 
5.2.6 The density for leucine 156 confirms sequencing 
results. 
Sequencing results reported in chapter 4 revealed that the initial sequence of the 
wild-type enzyme contained a leucine at residue 156 and not a serine as previously 
reported. This was also confirmed by the electron density and was particularly 




Figure 5.9 	Density around residues A 155 to A 157 of KK68_nabh_pl_2. The density 
for residue 156 can be seen to be excellent and is confirmed as a leucine. Electron density 
is of a 21F01-IFJ map (produced using FFT [79]) and is contoured at 1 sigma. 
5.3. 	Structure of wild-type type I dehydroquinase from 
S. typhi co-crystallised with dehydroquinate. 
One structure of wild type type I dehydroquinase from S. typhi was solved where the 
crystal had been grown in the presence of dehydroquinate and not reduced 
(designated KK68_coxtal_pll). In all structures with product irreversibly bound by 
reduction there is a distortion around the C3 carbon of the product. This structure 
was therefore important to identify any differences in the active site without this 
distortion. 
Due to this crystal being in the same spacegroup and a similar unit cell to 
KK68nabhpl_1 molecular replacement was not needed for structural solution and 
the KK68 nabhp 11 structure was used directly as a starting model for refinement. 




Cell a,b,c (a,,y 0)  
Collection Temperature 
Data Range A (High shell) 
R sym % (High shell) 
Completeness (high shell) 
1/sigi (high shell) 
Multiplicity (high shell) 
Number of unique reflections 
Number of protein 





42.96, 44.52, 77.44, 
(94.81, 98.03, 118.87) 
100 Kelvin 










Resolution range (A) 	 12.0 - 1.95 
Reflections used (Rfreeset) 	 31424 (1667) 
Rcryst (Rfree) % 	 17.96 (26.6) 
r.m.s.d bond lengths / Angles 	0.061 / 0.055 
Average B main/side chain 	 17.32/25.12 
Table 5.3. 	Processing and refinement statistics for structure KK68_coxtal_pl_1. 
5.3.1 	The co-crystal structure has a near identical fold 
to reduced structures. 
Overlaying of the KK68 coxtalp 11 structure and any of the previously discussed 
reduced structures reveals that they are near identical with no significant differences 
(Figure 5.11). 
Figure 5.11. 	Overlay of KK68_coxtal_pl_1 dimer (red) with that of the original published 
structure (blue) [44]. Average RMSD for all main chain XYZ positions = 0.53 A 
In addition the Hh loop of this structure is also closed with residue 236 positioned in 
the active site. Density for the residues of this loop is complete indicating that the 
loop is well ordered in this position (Figure 5.12). 
Lys 229 
(un 230 ' 
4 Ala 227 
?wxz 
4 
Pro 234 	 lie 237 
Figure 5.12. 	Electron density of A chain Hh loop of KK68_coxtal_pl_1. Electron density 
is of a 21Fj-IFj map (produced using FFT [791) and is contoured at 1 sigma. 
5.3.2 	The active site contains significant differences to 
reduced structures. 
On modelling the expected dehydroshikimate into the active site of this structure it 
became apparent that some changes had occurred to the active site in comparison 
with the borohydride reduced structures. Refinement of His 143 in a position 
obtained from those structures containing reduced product resulted in significant 
amounts of F0 -Fj difference electron density in a position closer to the C2 carbon 
of the product. Modelling and refinement of the product and its usual partner, water, 
in the position of reduced structures resulted in a large amount of 	difference 
electron density between the CI carbon of the product and the water (Figure 5.13). 
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Figure 5.13. 	Electron density of KK68_coxtal_pl_1 with dhs modelled into active site. 
21F01-IFI density is coloured blue and contoured at 1 sigma. IF01-IFI is coloured red and 
contoured at 2.5 sigma (produced using FFT [79]). For clarity no density is shown around 
lysine 170 although this residue is well defined in density. 
When the substrate was modelled into the active site in place of the product and its 
partner water removed strong F0-FI difference electron density was apparent in the 
position the removed water had occupied. In addition when His 143 was positioned 
closer to the C2 carbon of the substrate strong IFO HFC I was present in the previous 
histidine position. The density surrounding the new histidine position was well 
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Figure 5.14. 	Electron density of KK68_coxtal_pl_1 with dhq modelled into active site. 
21F0I-FI density is coloured blue and contoured at 1 sigma. IF0I-I17I is coloured red and 
contoured at 2.5 sigma (produced using FFT [791). For clarity no density is shown around 
lysine 170 although this residue is well defined in density. 
Positioning of waters into the IF0I-IF1 difference density was not possible as these 
positions were too close to either the substrate or His 143. It was therefore apparent 
that the histidine was in two distinct positions and that there was a mixture of 
substrate and product in the active site (Figure 5.15). This situation was apparent in 
the active sites of both monomers in the dimer. 
Occupancy refinement was performed in SHELXL [77] initially allowing both 
histidine positions and the substrate/ product/ water mix to refine individually from 
each other. Comparison of the resulting occupancies of each histidine position with 
those obtained for the substrate and the product ! water revealed that the more C2 
positioned histidine had occupancy close to that of the substrate. Similarly the 
product had occupancy similar to that of the histidine when it was orientated towards 
the Glu 86 position. Subsequent refinement of occupancy was performed with the 
substrate linked to the C2 oriented histidine and the product ! water linked to the Glu 
86 oriented histidine. The final refined occupancies resulted in 0.53 and 0.47 in the 
A monomer and 0.59 and 0.41 in the B monomer. In both cases the higher 
occupancy was for the substrate and the histidine in the more C2 position. This is 
surprising as the reported Keq for type I dehydroquinase from S. tvphi is 15 to I in 
favour of the production of dhs. This may indicate that the reported Keq is incorrect 
but more likely is because of the different conditions that crystals are grown under 
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Figure 5.15. 	Stereo image of combined 21 F.1-IFI density maps for doubly occupied dhq 
and dhs in active site. Dhq and its partners are coloured green. Dhs and its partners are 
coloured blue. All other residues are coloured as CPK standard atom types. Electron density 
(produced using FFT [79]) is contoured at 1 sigma. 
Comparison of these active site positions with the reduced active site positions 
shows the histidine 143 position in the reduced structure to be in an intermediate 







Figure 5.16. 	Overlay of KK68_coxtal_pl_1 A chain active site with that of 1OFE A chain 
active site. Dhq position and its partners from KK68coxtal_p1_1 are coloured green. Dhs 
position and its partners from KK68_coxtal_pl_1 are coloured blue. All other sidechains 
from KK68_coxtal_pl_1 are coloured by the CPK convention. Dhs and all sidechains of 
1QFE [44] are coloured red. 
It is also apparent from this overlay that the C3 carbon of the substrate / product has 
a different orientation in relation to lysine 170. In the borohydride reduced structures 
the NZ of lysine 170 and the C3 of the product are oriented towards the NE2 of 
histidine 143 and is due to the C3 carbon being sp3 hybridised in the NaBH4 reduced 
structures rather than the sp2 found in the substrate/product co-crystal. This has the 
effect of making the lysine and substrate/product significantly more planar. 
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5.4 	Structures of native wild type type I 
dehydroquinase from S. typhi. 
Two structures of wild type type I dehydroquinase from S. lyphi with nothing bound 
in the active site were solved (structures designated KK68_native_p 1_i and 
KK68native_pll. 







Spacegroup 	 P1 
Cell a,b,c (u,13,y°) 	 43.09,45.07,79.50, 
(95.86,97.77,118.39) 
Collection Temperature 	Room temperature 
Data Range A (High shell) 19.92-2.80 (2.95-2.8) 
Rsym % (High shell) 	 7.5 (15.8) 
Completeness % (high shell) 	93.9% (92.5%) 
1/sigi (high shell) 	 3.8 (3.9) 
Multiplicity (high shell) 	2.2 (2.1) 
Number of unique reflections 	12607 
Number of protein 
monomers in A.0 
	
2 






(90, 104.65, 90) 
Room temperature 
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Table 5.4. 	Processing 	statistics 	for 	structures 
	
KK68native_pl _1 	and 
KK68_nativep2l _1. 
The structure of KK68 nativepl_1 was already in a well established unit cell. The 
structure of KK68nativep2 1_i was in a new unit cell and so was again solved 
using molecular replacement. The original published structure (1QFE [44]) was used 
as the starting model for molecular replacement. 
Molecular replacement results are shown in table 5.5 
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solution of kk68native_p211 
first 7 rotation function peaks; 
*SOL_ 	ALPHA 	BETA 	GM5A 	THETA 	PHI 	CHI 	 RF 	RF/SIGMA 
SOL_RF 1 351.69 79.07 159.58 40.43 6.06 157.94 0.4427E+06 9.92 
SOL_RF 2 171.83 78.21 159.19 107.11 -83.68 82.59 	0.4037E+06 9.04 
SOL_RF 3 186.11 78.30 23.15 139.92 -8.52 157.41 0.3872E+06 8.67 
SOL_P.F 4 	6.13 77.56 23.07 72.58 81.53 82.06 0.3455E+06 7.74 
SOLRF 5 190.38 81.22 355.29 139.36 7.54 175.70 0.2525E+06 5.66 
SOLRF 6 	169.40 	88.24 319.53 	47.06 -165.07 143.95 	0.1695E+06 3.80 
SOL_RF 7 282.17 68.05 294.67 144.57 83.75 149.63 0.1693E+06 3.79 
Top 5 peaks found in dyad search; 
Sol_ 	1 	1 	1 	0 	1 	2 0.600 0.882 0.876 1.01 -1.48 	0.405 0.492 
Sol_ 1 4 1 0 1 1 0.600 0.883 0.875 1.01 -1.91 0.356 0.564 
Sol_ 	2 	4 	1 	0 	1 	1 0.772 0.000 0.372 1.00 -2.38 	0.453 0.387 
Sol_ 3 4 1 0 2 1 0.716 0.077 0.632 0.64 -1.47 0.464 0.378 
Sol_ 	4 	4 	1 	0 	1 	2 0.917 0.804 0.132 1.01 -1.44 	0.403 0.509 
used solution; 
Sol-best 	1 	4 	1 	0 	1 	1 0.600 0.883 0.875 1.01 -1.91 	0.356 0.564 
Table 5.5. 	Molecular replacement solutions for crystal KK68_native_p21_1. The 
highlighted solution stems from rotation peaks 1 and 4.(Tables produced as part of the 
output for the program MOLREP [75]). 





Reflections used (Rfreeset) 
Rcryst 9s (Rfree) 
r.m.s.d bond lengths/Angles 
Average B main/side chain 
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Table 5.6. 	Refinement 	statistics 	for 	structures 	KK68_native_p1_1 
	
and 
KK68_native_p21_1. KK68nativep21_1 refinement performed by Dr. Y. Xu. 
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5.4.1. 	The native structures are similar in overall fold. 
Overlaying of dimers from both native structures reveals that little difference is 
found in the overall topology of these structures. Similarly when overlaid onto any 
of the structures containing the substrate / product in the active site the overall 
structures are very similar. 
The most apparent difference between these structures is in the positioning of the Hh 
loop which is not in the closed conformation apparent in those structures containing 
the substrate / product (Figure 5.17). 
Figure 5.17. 	Overlay of native dimers with those of the original published structure. The 
open Hh loop conformation is circled in green. Average RMSD for all main chain XYZ 
positions = 0.63 A. 
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5.4.2 	The Hh loop is disordered in all native monomers. 
When modelled in the published closed position the electron density for the majority 
of atoms on the Hh loop was poor and not defined. This was the case for both native 
structures and all monomers. This indicated that in these structures the Hh loop was 
not in the closed position. Attempts to remodel the Hh loops of both native structures 
using simulated annealing in the program CNS failed to give reasonable density and 
these loops were subsequently modelled by eye. The final density for these regions 
was incomplete but did indicate that these loops were in the more open position 




Figure 5.18. 	2IF0I-IFI electron density around Hh loops of structures KK68_native_pl_1 
(left image) and KK68. native_p21_1 (right image). Both structures are shown in a similar 
orientation. Electron density is shown for the A chains only. Electron density (produced 
using FFT [79]) is contoured at 1 sigma. 
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5.4.3 	The native active site shows a number of 
differences to those containing substrate I 
product. 
Overlaying of native active sites reveals them to be similar, with little to no 
difference between monomers (Figure 5.19). Overlaying of active sites containing 
ligand onto those of the native structures reveals differences in side chain positioning 
of important residues (Figure 5.19). Histidine 143 takes a position similar to that of 
the reduced structures. Met 203 and Arg 213 show considerable movement and are 
directed towards the entrance of the active site. Movement is also apparent in Phe 
225. No movement is apparent in the His 143 or Glu 86 sidechains. 
Arg 203 





Figure 5.19. Overlay of active sites of native structures of type I dehydroquinase and an 
active site from KK68_nabh_pl_1. An active site from KK68_nativepl_1 is shown with 
carbons coloured green. KK68_native_p21-1 is shown with carbons coloured orange. All 
other atoms are coloured by CPK convention. 
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5.5 	Discussion. 
All of the structures described here show very similar conformations in both 
individual monomers and in their dimers. Large differences are only apparent in the 
crystallographic packing between structures and in the conformation of the Hh loop. 
Overlays of the structures described here reveal little variation between the structures 
despite their different packing forms. This similarity suggests packing has little to no 
affect on all structures and adds credibility to any active site differences being a 
result of the presence / absence of ligand. 
In all monomers containing ligand / substrate the conformation of the Hh loop is in 
the closed position and the density around the loop is well defined. In all native 
monomers the Hh loop is not in this position and is disordered. This would suggest 
that in native structures the Hh loop is in a more open conformation and is capable of 
adopting several conformations. This looseness and more open conformation makes 
the active site more accessible for the substrate. 
Despite the disorder of the Hh loop in native structures the positioning of the loop 
appears to agree with the structures of Lee et a! [46]. In the native structures reported 
here the Gly 235 - Ala 252 hydrogen bond is forming and does appear to be acting 
as a "latch", holding the Hh loop open, as suggested by Lee et al, in order to ensure 
substrate access is facilitated. The more stable position, removing hydrophobic 
residues from solution would hinder such access. 
In the borohydride reduced structures the Hh loop is also closed and well defined, 
suggesting that the opening of the loop to allow product release occurs at some stage 
after that shown in the reduced structures. The mechanism for the reopening of the 
Hh loop and release of product is unclear as the substrate and product are both 
capable of hydrogen bonding to serine 236. At some stage however the hydrogen 
bond between Glu 236 and the product must be broken to allow the release of the 
product. 
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Other differences between structures occur within the active site of the enzyme. The 
positioning of serine 236, methionine 203 and Arg 213 differ between native 
structures and those containing substrate / product. This appears solely to be a result 
of binding of substrate / product and the repositioning of the Hh loop. 
In the kk68coxtal_pll structure the presence of both substrate and product in the 
active site of both monomers gives a snapshot of movement of active site residues 
not solely involved in binding. In this structure the most obvious difference in 
residues from those of the borohydride reduced structures is in the positioning of 
histidine 143. The alternate positioning of this residue would appear to confirm the 
hypothesis that histidine 143 is orientated towards the C2 proton of dehydroquinate 
to allow it to act as the general base in the reaction. The hypothesis that glutamate 86 
and its loop are responsible for the orienting of this histidine is not confirmed. In the 
presence of the substrate His 143 and Glu 86 are not directly interacting. In the 
presence of product His 143 and Glu 86 are interacting through a direct hydrogen 
bond. No movement is seen of Glu 86 and its loop in all of the structures described 
in this chapter. This would appear to suggest that Glu 86 has the purpose of orienting 
His 143 away from the c2 proton of the product, perhaps to ease the binding and 
release of the substrate / product. 
The kk68coxtalpll structure is not solely of interest for the insight it gives to the 
mechanism of action. This structure is also of interest because it is not clear why the 
active site contains both substrate and product at levels that are clearly definable. It 
has previously been shown that the equilibrium of this enzyme is towards the 
production of large amounts of product in a ratio of 15 to 1 [30]. If these conditions 
were satisfied in the crystal then no evidence of substrate should be present in the 
density. The crystallisation conditions of this and all crystals discussed are at pH 6.0, 
far below the optimum for the activity of the enzyme, pH 7.2. This would result in 
the dramatic decrease of the enzyme activity and perhaps a shifting of its 




Structural solutions of active site mutant type I 
dehydroquinases from S. typhi. 
	
6.1 	Introduction. 
The results of kinetic studies on the produced mutant enzymes indicated an effect of 
these mutations on activity. It was therefore necessary to obtain crystals of these 
mutants with and without substrate/product in the active site. This was to gain an 
insight into the structural basis of the activity decrease observed for these mutants. 
6.2 	Structures of Asp 86 mutant type 
dehydroquinase from S. typhi. 
Crystals of the Asp 86 mutant of type I dehydroquinase from S. typhi were grown in 
their native unbound form and co-crystallised using the same crystallisation 
conditions as those used for the wild type enzyme. Data was collected for a single 
crystal of the native Asp 86 mutant and a single co-crystal. 
Processing statistics are summarised in table 6.1. 
Crystal Asp86coxtalp211 
Data Processing. 
Spacegroup P21  
Unit Cell a,b,c 	(a,13,y 
0)  60.43,46.08,85.44 
(90, 	95.78, 	90) 
Collection Temperature Room temperature 
Data Range A (High shell) 30-2.6 	(2.74-2.6) 
R sym % (High shell) 10.1 (23.6) 
Completeness (highshell) 97.8% 	(96.9%) 
I/UI (high shell) 5.8 (3.1) 
Multiplicity (high shell) 2.9 	(3.0) 
unique reflections 14674 
Number of protein 
monomers in A.0 2 
Matthew's Coeff 2.lA3  
% solvent 42.4% 
Asp_nativej2 l_l 
P21  
67 .24,156.74,97 .49, 









2. 3A3  
46.7% 
Table 6.1. 	Processing statistics for Asp 86 crystals co-crystallised with dhq and in the 
native form. 
The Asp86_coxtal_p2 1_i crystal was in the same spacegroup and a similar unit cell 
as the original published structure [44] and so the published structure was used 
directly in refinement. 
The Asp_native_p2 1_i solution was found to be in a new unit cell and so molecular 
replacement was used to find the solution of this structure (molecular replacement 
performed by Dr. Yan Xu). The dimer form of the original published structure (pdb 
code; 1QFE) was used as the search model. 
Final refinement statistics are given in table 6.2. 
Crystal 
	
Asp8 6coxtal_p2ll Asp_nativej2l_l 
Refinement. 
Resolution range 
Reflections used (Rfreeset) 
Rcryst % (Rfree) 
r.m.s.d bond lengths/Angles 
Average B main/side chain 










Table 6.2. 	Final refinement statistics for structures AsP86_coxtal_p21_ and 
Asp—native—p21-1. Refinement of Asp—native—p21-1 performed by Dr. Yan Xu. 
6.2.1. 	The Asp 86 mutant structures are similar in overall 
fold. 
Overlaying of dirners from both Asp86_coxtalj2 11 and Asp_native_p2 11 
structures reveals that their overall fold is very similar (Figure 6.1). Only a 
difference in the positioning of the Hh loop can be found. This is similar to the 
situation found in wild-type structures. 
Figure 6.1 Overlay of all dimers from the Asp86_coxtal_p21_1 and Asp—native—p21_1 
structures. Average main chain RMS XYZ displacement = 0.976 A. 
Overlaying of dirners onto the original published structure also reveals them to be 
similar in overall structure (Figure 6.2). This indicates that the mutation presented 
here has no gross effect on the enzyme, which is keeping with the earlier kinetic 
results. 
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Figure 6.1 	Overlay of all dimers from the Asp86_coxtal_p21_1, Asp—native—p21...1 
structures and 1QFE (yellow). Average main chain RMS XYZ displacement = 0.92 A. 
6.2.2. 	Comparison of Asp 86 mutant active site and that 
of the wild-type. 
The electron density for active site residues in both Asp 86 structures is well defined. 
In the Asp86 coxtalp2l_l structure density for product is clearly evident. In this 
structure there is no evidence for substrate. No evidence is seen in either structure for 
movement of the His 143 residue (Figure 6.3). Similarly no movement of the 86 loop 
is apparent in any of the monomers presented here. 
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Figure 6.3 Stereo image of the electron density for the active site of the 
Asp86_coxtal_p21_1 structure. Electron density is shown for the A chains only. Electron 
density (produced using FFT [79]) is contoured at 1 sigma. 
Analysis of density around residue 86 clearly indicates that this residue is an Asp 
and not the Glu of the wild-type enzyme (Figure 6.4). The only apparent difference 
between these structures and those of the wild-type is in the Asp86 - His 143 
interaction when compared to the G1u86 - His 143 interaction (Figure 6.4). Although 
the Asp 86 is shorter than Glu 86 the interaction between residue 86 and His 143 is 
similar in both. The Asp 86 side chain moves resulting in its 0D2 atom being in a 
similar position to the OE 1 of the Glu 86 side chain and therefore the Asp 86 mutant 
is still able to interact with His 143 via a hydrogen bond. This is slightly longer than 
in the Glu 86 structure (Glu 86 = 3.0 A, Asp 86 = 3.15 A) and may have the result in 
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Figure 6.4 Stereo image of the electron density around Asp 86, His 143, Lys 170 and dhs. 
The position of Glu 86 has been overlaid and can be seen to be out of density. Hydrogen 
bonds are shown as dashed red lines between Asp 86 and His 143 and Glu 86 and His 143. 
Electron density (produced using FF1 [79]) is contoured at 1 sigma. 
6.3. 	Structures of Gin 86 mutant type i dehydroquinase 
from S. typhi. 
Crystals of the Gin 86 mutant of type I dehydroquinase from S. typhi were grown in 
their native unbound form. Co-crystals of these were also grown in the presence of 
dhq but these crystals were not of the same quality. Data was therefore collected on a 
single native crystal. Soaking was also attempted on crystals grown in the same drop 
as the crystal that was used for native data collection. 1 j.il of IM dhq was added 
directly to this drop (initial drop volume 5jil protein solution / 5j..tl well solution and 
pre-equilibrated for 48 hours over 50% MPEG 5000) and left for 2 hours. A crystal 
was removed from this drop in a cryo-loop and immediately frozen in liquid 
nitrogen. This crystal was found still to be of diffraction quality. 
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Unit Cell a,b,c (a,3,y °) 
Collection Temperature 
Data Range A (High shell) 
R sym (High shell) 
Completeness (highshell) 
i/oi (high shell) 
Multiplicity (high shell) 
Unique reflections 
Number of protein 
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38.8% 
G1n8 6native_p2 1_i 
P21  
59.38,44.19,83.96, 
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Table 6.3 Data collection and processing statistics for structures G1n86_soak_p21_1 and 
G1n86_native_p21 _1. 
6.3.1. 	Soaking of crystals resulted in damage of 
crystals. 
Although the Gln86_dIqsoakp2 1_i crystal did survive the soaking process 
evidence of damage to this crystal was readily apparent. Although both the native 
and the soaked crystals were grown in the same crystallisation drop, and were of a 
similar size and apparent quality, a dramatic loss of resolution resulted from the 
soaking process (Table 6.3). It was also apparent from analysis of the diffraction 
patterns that the spot shape of reflections from the soaked crystals was not as well 
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Figure 6.5. 	Comparison of diffraction patterns of native (left) and dhq soaked Gin 86 
mutant crystals. The streaking of reflections from the soaked crystal can be clearly seen on 
close up. 
Despite this damage processing of the soaked crystal data was still possible and the 
resultant structure solved and refined. Both native and soaked crystals were found to 
be in the same spacegroup as the original published structure and so this structure 
was used directly in refinement. 
Refinement statistics are given in table 6.4. 
Crystal 	 Gln86soak_p2 1_i 	G1n86_native_p2 1_i 
Refinement. 
Resolution range A 	 20 - 2.32 	 15 - 1.45 
Reflections used (Rfreeset) 	18354 (990) 75168 (3978) 
Rcryst (Rfree) % 	 22.45 (31.37) 	19.61 (22.88) 
r.m.s.d bond lengths/Angles 	0.074/4.616 0.028/2.135 
Average B main/side chain 20.732/23.612 	16.82/24.25 
Table 6.4. 	Final refinement statistics for structures G1n86_soak_p21_1 and 
G1n86_native_p21 _1. 
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6.3.2. 	The Gin 86 mutant structures are similar in overall 
fold. 
Overlaying of dimers from both the Gln86soak_p21_l and Gln_native_p21_l 
structures reveals that their overall fold is very similar (Figure 6.6). Overlaying of 
dimers onto the original published dimer also reveals that there are no gross 
structural changes in either of these structures when compared to the original. This 
also indicates that the mutation does not cause any large changes to the structure of 
these enzymes, confirming earlier kinetic results that any change would be a subtle 
one (Figure 6.6). 
Figure 6.6 Overlay of dimers for all GIn 86 mutant structures with that of the original 
published structure (1QFE [44]). The G1n86_soak_p211 dimer is coloured red, the 
GIn_native_p21_1 dimer is coloured yellow and 10FE is coloured blue. Average main chain 
RMS XYZ displacement = 0.35 A. 
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6.3.3. 	The Hh loop is closed in all monomers. 
In other comparisons of this sort native structures have all shown a tendency to have 
an open Hh loop, or at the very least a disordered one indicating flexibility in this 
region. This is not the case in these structures as the Hh loop in all monomers is 
closed and in well defined density. This is not surprising in the G1n86 soap2 1_I 
structure as in this structure the reaction product is bound in the active site and in all 
structures of this sort so far found, the Hh loop has been found to be closed. In the 
native structure however the Hh loop in both monomers is also in the closed 
position. This situation has not been observed in any of the other native forms of the 
enzyme. The density for the Hh loop of the A chain is very well defined and shows 
no sign of disorder in any of the backbone atoms and very little disorder in side-
chain residues. The density for the Hh loop of the B chain is less well defined with 
disorder in a number of the residues; however density is present for this loop in the 
closed position and appears to indicate that this loop is also closed (Figure 6.7). 
Pro 234 
Figure 6.7 Electron density around the Hh loop of the Gln_native_p21_1 structure. Left 
image is of the A chain and right image is of the B chain. Electron density (produced using 





6.3.4. 	Comparison of G1n86 mutant active site and that 
of the wild-type. 
The electron density for the active sites of both structures is excellent and in both 
structures the presence of the Gln 86 residue is confirmed by the density. This is 
particularly evident in the higher resolution native structure (Figure 6.8). The 
orientation of the Gln 86 residue was established through B factor refinement and the 
OE  atom of the Gln 86 side chain was established as being oriented towards the His 
143 residue. 
Figure 6.8 Stereo diagram of the relationship of Lys 170, His 143 and Gin 86 in the 
Gin86_native_p21_1 structure. Density for each residue is shown. Position of Glu 86 has 
been added and can be seen to overlay with Gin 86. Electron density (produced using FFT 
[79]) is contoured at 1 sigma. 
Of particular interest is the presence of F0-FI difference electron density in the 
active site of the soaked structure. When the Gln86soakp211 structure is refined 
with histidine 143 in the original published position the presence ofIF,,I-lFc l  
difference density is observed between the Histidine and the G1n86 side-chain 
(Figure 6.9). The positioning of this 	density is too close to the histidine for it 
Lys 170 
to be thought of as water. This is therefore a further indication of the histidine 
moving towards the Gin 86 side-chain in a similar manner to the movement of the 
KK68coxtal_pll His143 side-chain (Chapter 5, section 5.3.2). In the 
KK68_coxtai_p 11 structure there is also evidence for the presence of substrate. In 
the G1n86 soakj2l 1, there is no evidence for the substrate and only density for 
the product appears to be present. Due to the lack of the substrate in this structure 
and the weakness of the additional F-IFJ the histidine has only been modelled into 
the strongest density position. 
Figure 6.9 Stereo picture of the electron density around dhs, Lys 170, His 143 and Gin 86 
of the G1n86_soak_p21_1 structure. 2IFj-IFI  density is coloured blue and contoured at 1 
sigma. F0I-IFI  is coloured red and contoured at 2.5 sigma (produced using FFT [79]). 
The active sites of the G1n86 nativep21 I structure are also of interest because of 
the closed position of the Hh loop. In the active site of chain A a triangular shaped 
portion of density was evident in a similar position found for the carboxyl group of 
the substrate / product in co-crystallised and reduced structures. Analysis of the 
crystallisation medium indicated that this was likely to be an acetate molecule. 
Acetate is a known weak inhibitor of type I dehydroquinases (Ki = 103 mM, Prof J. 
Coggins, personal communication). On modelling and refinement this appeared to be 
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correct (Figure 6.10). The B chain also has a closed loop, but this is not so well 
defined and no strong density is apparent that can be attributed to an acetate 
molecule. There is one peak of density in this region which is within hydrogen 
bonding distance to the Gin 236 side-chain. This peak has been designated as 
belonging to a water molecule although it may also indicate the presence of a lower 
occupied acetate. 
Figure 6.10 Stereo picture of the electron density of the active site of the 
Gln86_native_p21_1 structure. Acetate is in strong density. Dhs has been modelled into its 
binding position (coloured green) and can be seen to overlay the acetate and waters. 
Electron density is shown for the A chain only. Electron density (produced using FFT [79]) is 
contoured at 1 sigma. 
Overlaying all of the Gln 86 active sites with those of the original published 
structures reveals the side chain conformations of all active site residues to be 
remarkably similar. The only significant differences are in the positioning of the side 
chain of residue 86. In the Gin 86 mutants this has shown a slight movement away 
from the ND I of histidine 143. Resulting in a very slight increase in the hydrogen 
bond distance between these two residues (2.81 A in 1QFE chain A and 2.99 A in 
Gln86soakp2ll chain A). As a result of this the Gin 86 side chain is moved 
ID 
closer to the backbone N of His 143 (2.8 A in Gln86soak_p211 chain A and 3.06 
A in 1QFE chain A). 
6.4. 	Discussion. 
The structures of mutant type I dehydroquinase are all very similar to those of the 
wild type enzyme. From the kinetic results (Chapter 3, section 3.4) it is clear that the 
mutant enzymes are still active and have kinetic values close to that of the wild type 
enzyme. Therefore no large scale structural changes in the form of domain shifts or 
loop movements were expected. Differences were expected in the relationship of the 
mutant side chains and the side chain of the His 143 residue. Further movement of 
the 86 loop was also expected. Very little difference is apparent between mutant and 
wild type structures. In the mutant structures the 86 sidechain has moved to still 
allow formation of the hydrogen bond between the 86 residue and the His 143 side 
chain but the loop supporting this residue shows no sign of movement. This 
compensation, although small, may explain the subtle change observed in kinetic 
analysis. The result of this could be a weakening of the 86 to 143 interaction and so 
consequently weakens the effect of the 86 loop on the orientation of His 143. 
Two aspects of the GIn 86 mutant structures are of particular interest. The existence 
of F0I-Fl  difference density in the G1n86_soakp2 1_i structure suggests movement 
around chil of His 143. This confirms earlier results with the kk68coxtalpll 
structure (Chapter 5, section 5.3) for the His 143 sidechain being able to move 
towards and away from the C2 proton of the substrate/product as the reaction 
progresses. 
Also of interest is the Gln86 nativep2 1_i structure which contains acetate in one of 
its two active sites and possibly acetate in the other. This structure clearly shows the 
specificity of the active site of type I dehydroquinase. The structure of the 
substrate/product is mimicked in this active site by the presence of water at the 
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position of the CS hydroxyl of the substrate/product. Two waters are found flanking 
the position of the C4 hydroxyl. The acetate is found at almost exactly the position 
of the carboxyl group of the substrate/product and is hydrogen bonding to the side 
chains of Gin 236 and Arg 213. No other waters are present within the active site and 
all active site side chains take the same positions as those structures that contain the 
substrate/product. The lack of any further water molecules within the active site 
suggests that only these positions are available for hydrogen bonding. This 
positioning of waters at the hydroxyl positions is also present in native structures. 
The position of the acetate molecule at the carboxyl position reveals the exquisite 
specificity of the enzyme in this region of its active site. Acetate is of a size that it 
can physically fit in a number of orientations within the active site; the hydrophobic 
nature of Phe 225 at the back of the active site and the hydrophilic nature of Arg 213 
prevent this and only allow acetate to be in this position. This positioning also allows 
the Hh loop to be stabilised in its closed position despite the weak binding of acetate, 
indicating that only this hydrogen bond need form for the closure of this loop to take 
place. 
The differences observed between both active sites of the Gln86nativep2ll 
structure are also of interest. Although the Hh loop is contained in density for both 
loops, this density is much stronger in the A monomer than in the B monomer. 
Similarly the density for acetate is much more obvious in the A monomer than in the 
B monomer. This difference might reflect differing levels of occupancy between the 
acetates of each active site or greater levels of mobility in the B subunit. This is 
indicated by the B factors for each subunits Hh loop which are considerably higher 
for the B subunit (c(x Gin 236, A subunit 18, B subunit 33). This is likely a 
consequence of slightly different environments within the crystal. This is seen 
because of the relatively low concentration of acetate in the crystallisation medium 
with regards to its Ki. 
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Chapter 7. 
Studies of putative inhibitors of type I 
dehydroquinase from S.typhi. 
7.1 	Introduction. 
Inhibitory drugs are molecules which block the action of a protein by the binding to 
that protein and in doing so bring about the proteins inactivation. These inhibitors 
may act directly in the proteins already present substrate binding pocket or in an 
allosteric fashion by acting on another region of the protein. Both these inhibition 
mechanisms are found in protein kinases [93, 94]. The rational design of inhibitory 
drugs via structural techniques is dependant on accurate data about the binding of 
those inhibitors in the binding region of the target protein. These data are in the form 
of kinetic data to give a measure of the strength of binding of these ligands and in 
the form of detailed structural information. Structural information may be used for 
database mining and homology modelling techniques to obtain new or improved 
inhibitor leads [94 95]. Because of the importance of the shikimate pathway as a 
potential antibmicrobial drug target, inhibition studies were performed utilising 
kinetic techniques on potential inhibitors of type I dehydroquinase from S. typhi. 
Attempts were also made to solve the structures of some of these inhibitors co-
crystallised with type I dehydroquinase from S. typhi. 
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7.2 	Inhibition studies of putative inhibitors and type I 
dehydroquinase from S.typhi. 
Putative inhibitors of type I dehydroquinase from S. typhi were chosen for there 
similarity in shape to the substrate/product of the enzyme. All compounds were 
tested via kinetic techniques and their Ki's calculated (table 7.1, Figure 7.1). The 
assay consisted of direct measure of the activity of the enzyme in the presence of the 
putative inhibitor and comparing this to the enzymes activity in the absence of the 
putative inhibitor. The assay used was the standard kinetic assay for measuring the 
production of dhs from dhq (Chapter 2, section 2.18). 
Table 7.1 List of the putative inhibitors tested and their resultant Ki's. 
Putative inhibitor Calculated Ki (mM) 
Glucose >20mM 
Quinic acid 8 mM +1- 10% 
Protocatechuic acid > 20 mM 
Galacturonic acid > 20 mM 
Glucuronic acid > 20 mM 
Shikimic acid 9 mM + / 10% 
Inositol > 20 mM 
L-Glucono-1 ,5-Iactone > 20 mM 




cyclohexene-1 -one  
> 20 mM 
5-phenyl cyclohexane-1 ,3-dione > 20mM 
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Figure 7.1. 	Hanes plot of kinetic results for wild type dehydroquinase with no putative 
inhibitor (blue points / line), inositol (pink points / line) and quinic acid (yellow points / line). 
([S] = dhq concentration iM v= Absorbance Units / min-'). 
Although the results of kinetic assaying the putative inhibitors 5-carboxy 
cyclohexane-1, 3-dione, 2-niethoxy-5-carboxy-1, 6- cyclohexene-1-one and 5-phenyl 
cyclohexane-1, 3-dione showed no measurable inhibition, attempts were made to 
irreversibly reduce these compounds onto Lys 170 by borohydride reduction. None 
of these compounds resulted in the inactivation of the enzyme and so confirmed 
kinetic results that these were not inhibitors of type I dehydroquinase. 
7.3 	Co-crystallisation of type I dehydroquinase and 
known inhibitors. 
Co-crystallisations were performed with the type I enzyme and the inhibitors 
established here. Co- crystals grew with 50 mM quinic acid data were collected and 
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the structure solved (Data not shown). This structure was found to contain no 
evidence of quinic acid and so was actually native. 
In previous studies a number of compounds have been found to inhibit type I 
dehydroquinase [96, 97] Three of these established inhibitors were produced by Dr 
K. Grant [96]. These inhibitors are shown in Figure 7.1. 
OH 000H 	HO COOH 	QH COOH 
%H OH 
OH 	 OH 
1.= —10 MM 	2=3mM 3.=4mM 
Figure 7.1. Structures and their Ki values of previously established type I dehydroquinase 
inhibitors. 1= 4,5-dideoxyquinic acid, 2=1 ,4,5-trihydroxycyclohex-2-ene-1-carboxylate, 3= 5-
deoxyquinic acid. 
Co-crystallisations were set up with each of these inhibitors at a concentration of 60 
mM and crystals grew for 1 ,4,5-trihydroxycyclohex-2-ene-1 -carboxylate. These crystals 
were found to diffract and data were collected. 




Cell a,b,c (a,,y 0)  
Collection Temperature 
Data Range A (High shell) 
R sym % (High shell) 
Completeness % (high shell) 
1/sigi (high shell) 
Multiplicity (high shell) 
Number of unique reflections 
Number of protein 





42.96, 44.52, 77.44, 
(90.0, 90.03, 90.0) 
Room Temperature 







2. 2A3  
44.8% 
Table 7.2. 	Processing statistics for structure KK68_inhib_p21 1. 
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Because of this structure being in a new spacegroup and unit cell molecular 
replacement was performed to solve this structure using the program MOLREP [75] 
(molecular replacement was performed by Dr. Yan Xu). Refinement was performed 
in the program REFMAC [76] and the modelling of the ligand was performed by eye 
(Modelling and initial refinement performed by Dr. Yan Xu). Final refinement 
statistics are shown in table 7.3. 
Refinement 	 KK68inhiby2ll 
Resolution range A 	 20 - 2.6 
Reflections used (Rfreeset) 	 26745 (1433) 
Rcryst (Rfree) % 	 18.22 (24.05) 
r.m.s.d bond lengths / Angles 	0.056 / 3.134 
Average B main/side chain 	 23.04/25.38 
Table 7.3. 	Refinement statistics for structure KK68_inhib_p21 _1. 
7.4. 	The inhibitor co-crystal structure has a near 
identical conformation to all other structures. 
Overlaying of the dimers of the KK68_inhibp2 1_i structure onto the original 
published structure reveals them to have a similar overall conformation. No large 
domain shifts are apparent in any of the monomers and no significant hinge 
movement has occurred between the monomers of each dimer (Figure 7.2). 
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Figure 7.2 Overlay of dimers from the KK68_inhib_p21_1 structure with that of the original 
published structure (1QFE [44], Yellow). Average main chain RIMS XYZ displacement = 0.42 
A. 
7.5. 	The Hh loop of all monomers is closed but 
disordered. 
Analysis of the electron density around the Hh loop of each monomer in the 
KK68_inhibp2l_l structure reveals that poor density is evident for the Hh loop 
when modelled into the closed position expected when there is a ligand binding in 
the active site. Modelling the Hh loop in the open position resulted in very little 
density for the Hh loop. This suggested that the Hh loop is primarily closed in this 
structure but is still flexible (Figure 7.3). 
Pro 23 
11e 
Figure 7.3 	2IF0I-IFI electron density around the Hh loop of the KK68_inhib_p21_1 
structure. Electron density (produced using FFT [79]) is contoured at 1 sigma. 
7.6. 	Density for inhibitor is only present in two of the 
four active sites. 
Analysis of electron density in and around the active site revealed density for the 
ligand. This density was only present in the active sites of two of the monomers in 
the structure and only present in one of the two dimers (Figure 7.4). The density for 









Figure 7.4 	2IF0-IFI 	electron 	density around the 	inhibitor found 	in the 
KK68_inhibp21_1 structure. Electron density (produced using FFT [79]) is contoured at 1 
sigma. 
7.7. 	Comparison of inhibitor bound active site and 
other active sites. 
Comparison of the active site of the inhibitor bound structure with that of a structure 
containing the reaction product reveals dramatic differences in the positioning of the 
inhibitor (Figure 7.5). 
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Phe 225 
0, 	rg 213 
GIti 46 
Figure 7.5 Stereo image of overlay of an active site from the KK68_nabh4_pl_1 structure 
(green) and an active site of KK68_inhib_p21_1 structure that contains 1,3,5-
trihydroxycyclohex-2-ene-1-carboxylate in the active site. 
The inhibitor is found positioned such that its carboxyl group is found in the position 
of the C5 hydroxyl of the product. The C4 hydroxyl of the inhibitor is positioned at 
the position normally associated with Lys 170 and the C4 hydroxyl of the product. 
As well as the dramatic change in the positioning of the ligand there are also 
movements in active site sidechains. The largest shift is for the Glu 46 side chain 
which is directed towards Ser 232 to accommodate the C5 hydroxyl of the inhibitor. 
The other major movement is in the Lys 170 side chain which is moved towards the 
His 143 sidechain to accommodate the hydrophobic nature of the C2 and C3 carbons 
of the inhibitor. 
All other side chains take the forrii of the substrate bound structure. It is unclear why 
the Hh loop is closed in this structure as no strong hydrogen bonds are being made to 
the sidechain of Gln 236. This motif has always been present in all other structures 
in which the Hh loop is closed. It may be that a weak interaction is occurring 
between the carboxyl of the inhibitor and the carbonyl of Ser 232 (3.4 A separation). 
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However this would require the carbonyl of Ser 232 to be protonated and this is very 
unlikely. 
7.8. 	Discussion. 
The ligand positioning when compared to structures containing reaction 
substrate/product was initially surprising. However when the inhibitor structure is 
compared to that of the substrate it becomes apparent that the lack of oxygen at the 
C3 position hinders the binding of this inhibitor. For the inhibitor to fit in the same 
position as the substrate a large movement of Lys 170 would be needed to 
accommodate fully the C3 carbon. This cannot happen due to restrictions on the 
lysine by both the active site hydrophobic nature and physically by the protein. 
Therefore it is perhaps surprising that this ligand binds at all. The ligand has 
accommodated itself into the active site by mimicking aspects of the substrate and 
causing movements in the active site side chains. 
The structure of 1,4,5-trihydroxycyclohex-2-ene-1-carboxylate in the active site of 
type I dehydroquinase reveals further the exquisite nature of the enzymes specificity. 
It is immediately apparent on examination of this structure that the inability of 
compounds to form a Schiff base with Lys 170 can dramatically change the 
positioning of the compound within the active site when compared to the 
substrate/product. Most of the compounds tested here are incapable of forming a 
Schiff base and it is likely that this is why the majority showed no measurable 
inhibition despite being otherwise similar to the substrate/product. The importance 
of Lys 170 in the binding of these inhibitors should be taken into account in the 
future design of inhibitors of type I dehydroquinase. 
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Chapter 8. 
Crystallisation trials of the dehydroquinase like 
domain of QutR from A. nidulans. 
	
8.1 	Introduction. 
The suggestion of Nicholas [52] that the proposed relationship of the QutR protein to 
that of the AROM protein is without foundation makes the structural solution of this 
protein of great interest and importance. Therefore attempts to obtain diffraction 
quality crystals were performed. 
8.2 	Crystallisation screening of the DHQase like 
domain of QutR from A. nidulans. 
A number of sparse matrix screens containing a large number of possible 
crystallisation conditions were initially set up. These covered various pH values, 
precipitant concentrations and types and a number of different buffering conditions. 
In all screens the initial protein conditions were; 25 mM phosphate buffer pH 7.2, 1 
mM DTT, 250 mM NaCl. Protein concentration was 15 mg/ml. All screens were set 
up at 4°C. 
Small needle clusters were found to form at 4°C in 0.2 M TAPS pH 8.5, 14 % w/v 





Figure 8.1. 	Initial crystals of QutR obtained from crystallisation screens. 
6.3 	Refinement of crystallisation conditions of the 
DHQase like domain of QutR from A. nidulans. 
A number of variations around those conditions established in initial screens were 
set up. Conditions were set up using different precipitants and precipitant 
concentrations. Precipitants used were ammonium sulphate, sodium citrate, MPD, 
PEG 4000, PEG 5000, MPEG 5000, PEG 6000 and PEG 8000. 
Crystals were capable of forming under all precipitant conditions. In all cases the 
crystals were small needle clusters. The largest of these (0.5 mm longest dimension) 
formed using MPEG 5000 as a precipitant and formed after one month at 4°C 
(Figure 8.2). These crystals were seen to start to degrade a month after their 
formation. 
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Figure 8.2. 	Improved crystals of DHQase like domain of QutR. Crystal pictured has 
been separated from a larger cluster and has a longest dimension of 0.5 mm. 
Adjustments to the buffer type and concentration did not result in improved crystals. 
Similarly varying the concentration of NaC1 did not result in the improvement of 
crystal quality. Attempts to set up crystallisations at temperatures higher than 4°C 
also did not result in crystal growth and the protein was seen to precipitate. 
Variations to the protein concentration also did not result improved crystals. 
Changing from TAPS buffer to another buffer did not result in crystal fornation. 
Crystal lisations were set up utilising an additive screen (Hampton research) which 
was also not seen to form improved crystals. In a similar manner crystallisation trials 
were set up containing 10 mM quinic acid, dhq, protocatechuic acid and shikimic 
acid as these are possibly ligands to the DHQase like domain of QutR. As with the 
general additive screen these also did not show improvements to the crystal size or 
quality. 
Difficulty was encountered over the reproducibility of crystallisation and sometimes 
resulted in no crystal formation. Due to the presence of phosphate in the protein 
solution salt crystals were seen to forrn in a large number of trials (Figure 8.3). 
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0.5 mm 
Attempts with other buffers as the protein medium (HEPES, MES) did not result in 
protein crystal formation. 
0.5 mm 
4 	10 
Figure 8.3. 	Examples of salt crystals formed under normal crystallisation conditions. 
Seeding was attempted with those drops in which crystals had previously formed. 
These resulted in small needles (<0.05 mm) which were individual and not observed 
in the previously obtained clusters (Figure 8.4). Subsequent attempts at macro-
seeding from these crystals did not result in larger crystals however. 
Figure 8.4. 	Examples of crystals formed from seeding. 
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8.4 Diffraction of crystals of the DHQase like domain of 
QutR from A. nidulans. 
Crystals that were large enough to be mounted (>0.1 mm) were tested for their 
ability to diffract. Tests were carried out at room temperature and 100 K. The 
majority of crystals showed no detectable diffraction and so it was unclear the effect 
of freezing on these crystals. Freezing solutions consisted of either 100 % Cargille 
type 1 immersion oil or the crystallisation well solution and 15 to 20 % glycerol. 
All crystals that were found to diffract were at 100 K. Diffraction from all crystals 
was found to be weak (> 5 A) tested at home on a rotating anode generator. A single 
crystal was tested at the SRS synchrotron radiation source station 14.1 at Daresbury 
(data collected by Dr L. Sawyer). This crystal had formed at 4°C in 0.2 M TAPS pH 
8.5, 15 % w/v MPEG 5000. Protein solution was 25 mM phosphate buffer pH 7.2, 1 
mM DTT, 250 mM NaCI with a protein concentration of 12 mg/mi. Diffraction of 
this crystal was also weak (>4 A). Diffraction was also disordered (Figure 8.5) and 
did indicate a streaking of the diffraction similar to that seen in crystals of type I 
dehydroquinase from S. typhi. Subsequent attempts to produce crystals at higher 
DTT concentrations did not result in improvement to crystal quality and 
consequently the diffraction from these crystals. No real unit cell information could 
be established from these crystals. 
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Figure 8.5. 	Diffraction of a single crystal of the dehydroquinase like domain of QutR. 
8.5 	Discussion. 
The poor quality of crystals of the dehydroquinase like domain of QutR that are 
described here was disappointing and all attempts to improve them failed. A number 
of reasons could be responsible for this lack of crystal quality. 
Analysis of the protein purification has shown that the protein is greater than 90% 
pure. However protein is seen to precipitate over a short period (48 hrs) when left at 
4°C indicating that the protein either degrades or aggregates over time and may be a 
factor in the poor quality diffraction of these crystals. Addition of protease inhibitors 
(PMSF) did not appear to have an effect on this degradation or aggregates. It is 
uncertain if this degradation is the breaking of the protein or an unfolding effect. 
Crystals were still capable of forming with older protein after precipitated protein 
was pelleted by centrifugation. SDS-PAGE run on old protein and compared with 
fresh protein did not suggest a breakdown product. Dynamic light scattering was 
also inconclusive. 
Although attempts at crystallisation were set up with additives it is not yet 
established what this protein binds, if anything. Due to its role in the metabolism of 
the quinic acid pathway it has been suggested that quinic acid or another related 
quinic acid pathway or shikimate acid pathway molecule may bind. In crystallisation 
trials these pathway intermediates did not have a noticeable effect. Similarly 
isothermal calorimetry tests on the dehydroquinase like domain of QutR have so far 
failed to reveal any molecules that QutR binds. (A. Hawkins personnal 
communication). 
The dehydroquinase-like domain is only a fragment of a much larger multi-domain 
repressor protein. It may be that due to this only being a fragment that by itself it is 
unstable and so will never crystallise satisfactorily. Similarly because it is only a 
fragment it is uncertain if the end points of the protein represent parts of external 
loops and therefore take no part in the structure of the domain. Modelling performed 
based on the sequence alignment and the dehydroquinase structure has proven 
difficult in the N-terminal region and may be a suggestion that this section is more 
than just a linker section in the whole multi-domain protein and is unstructured when 
only with this dehydroquinase domain (modelling performed by Dr. D. Cronin). 
Currently protease digests are being performed to establish the exact boundaries of 
this protein domain. 
This domain of QutR does show similarities in its crystal morphology to those of 
type I dehydroquinase. The streaking of the diffraction from these crystals is similar 
to that seen for dehydroquinase crystals. This was corrected in S. typhi crystals by 
the increasing of DTT in the crystallisation medium. This did not have a noticeable 
effect here but it was also not effective with E. coli crystals. It was also noticeable 
that like S. typhi dehydroquinase crystals the crystals of the dehydroquinase like 
domain of QutR showed degradation over time. In dehydroquinase crystals this was 
indicative of a return of streaking in the diffraction pattern. This streaking is always 
present in QutR crystals and so is probably unrelated. This degradation is possibly 
linked to the degrading of the protein and/or the protein quality. 
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It is tempting to suggest that the similarities in the crystal behaviour indicate a 
similarity between the QutR protein and dehydroquinase. This is by no means 
certain and is most likely a result of the poor quality crystal. The similarity of these 
two proteins can only be confirmed by the full structure solution of the QutR protein 




9.1 	Packing of type I dehydroquinase from S. typhi. 
Despite the different packing forms of type I dehydroquinase reported both 
previously and now in this work (table 9.1, 9.2)[44, 46] the observed conformation 
of all of these structures is very similar. In all structures a dimer is present in the 
asymmetric unit and no significant hinge movement is apparent between the 
monomers that form the dimer. The previously published crystal structures were all 
grown under similar conditions [42, 44, 46] with only small changes resulting in 
different packing forms. Despite being grown using different conditions to those 
published, one of the previously discovered crystal packing forms has been repeated 
here and a further 5 new crystal forms have also been discovered (Table 9.2). As was 
the case previously these crystal forms all resulted from very similar conditions. A 
fuller analysis of the packing of type I dehydroquinase from S. typhi is therefore 
warranted. 
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Crystal form A Crystal form B Crystal form B 
P222 	(a, b, c, (xj3,y 0)  P2 (a, b, c, a,l3,y 0)  P2 (a, b, c, al37 0)  
48.78, 112.33,42.94, 90, 90, 90 60.49, 45.39, 85.47, 90, 95.48, 90 42.61, 158.56, 85.89, 90, 93.61, 90 
Table 9.1. 	The three previously discovered crystal forms of type I dehydroquinase from 
S. typhi [44, 46]. 
Crystal Form 1 131 P1 P1 
a, b, c (aj3,y°) 43,39, 46.02, 79.6 42.96, 44.52, 77.44 43.09, 45.07, 79.50 
(95.99, 97.78, 118.22) (94.81, 98.03, 118.87) (95.86, 97.77, 118.39) 
Crystal Form 2 131 
a, b, c (aJ3,y ') 42.69, 79.5!, 80.88 
(109.3 1, 97.24, 90.0) 
Crystal Form 3 P2 
a, b, c(a,3,y°) 79.45, 40.48, 156.77 
(90, 104.65, 90) 
Crystal Form 4 P2 
a, b, c (cj3,y°) 42.96, 44.52, 77.44 
(90, 90.04. 90) 
Crystal Form 5 132 
a, b, c(a,13,y°) 67.24, 156.74, 97.49 
(90, 93.50, 90) 
Crystal Form 6 P2 1 P21  P21  
a, b, c (ca,13,y°) 60.43, 46.08, 85.44 59.68, 44.55, 84.25 59.38, 44.19, 83.96 
(90, 95.78, 90) (90, 95.91,90) (90, 96.47, 90) 
Table 9.2 Table of all crystal forms and their members established in this work. Forms 1 to 5 
are new. Crystal form 6 is classed as being the same as one of those crystal forms 
previously discovered (pdb code; 1QFE [44]). 
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Analysis by Lee [46] established that only three residues are conserved in their 
ability to form crystal contacts (Arg 38, Gln 59 and Asp 123) and these were found 
to form contacts with different residues in each form. Only Asp 123 formed the same 
contact in 2 of these forms. Each other contact was unique to each form. It was also 
observed by Lee [46] that each crystal form contained different numbers of crystal 
contacts (Table 9.2). 
In the work described here 6 packing forms of type I dehydroquinase from S. typhi 
were discovered. Of particular interest are the two crystal forms found in the P1 
spacegroup. Further analysis indicated that the kk68nabhpl_l structure is 
approximately half the unit cell volume of the kk68_nabh_pl_2 structure (133046 
A3 to 256214 A). Analysis of the unit cells indicated that the b axis of the 
kk68nabh_pl_2 structure is approximately double the length of the 
kk68nabh_plj structure (80 to 44 A, Figure 9.1). This indicated that the 
kk68nabh_p12 may in actual fact be in the same unit cell as the kk68_nabh_pl_l 
structure. All attempts to reprocess the kk68nabhpl_2 structure in the 
kk68nabhpll structure's unit cell failed and the data for the kk68_nabhpl_2 
structure could not be reduced to the smaller unit cell. 
Figure 9.1 View of the bc faces of the unit cell of structures kk68nabh_p1_1 (crystal form 
1, Table 9.2, left image) and kk68_nabh_pl_2 (crystal form 2, Table 9.2, right image). The 
unit cell is marked in red. kk68_nabh_pl_2 can be seen to contain approximately double the 
area of kk68_nabh_pl_1. Protein is a ca-trace and is coloured yellow. 
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Although the be and ab faces of both of these crystal forms are very similar, albeit 
double the volume in the KK68_nabh_pl_2 structure, the ac faces of these two 
crystals forms have no similarity (Figure 9.2). Therefore these two crystal forms 
although similar are unrelated. 
Figure 9.2. View of the ac faces of the KK68_nabh_plJ (crystal form 1, left image) and 
KK68_nabh_p12 (crystal form 2, right image). Protein is a ca-trace and is coloured yellow, 
Unit cell outlines are coloured red. 
Subsequent analysis of the diffraction patterns of kk68_nabhpl_2 revealed that 
some of the reflections from this crystal were actually streaked in a similar manner 
to that described in chapter 4 (section 4.4). The streaking of this crystal was to a 
much lesser degree than previously reported (Figure 9.3) and so the data could be 
processed in the larger unit cell. 
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Figure 93. Image of the diffraction of KK68_nabh_p12. Streaking of every second row 
of spots is apparent. 
Listing of all residues involved in protein to protein crystal contacts for both these 
structures reveals 19 residues involved in the KK68 nabh_pl 1 structure and 14 
residues in the KK68nabhjl2 structure (cut-off distance for contacts = 3.3A). 
Eight of these contact residues are conserved throughout all monomers in both 
structures. These 8 conserved contact residues combine to form 4 conserved crystal 
contacts. A further 3 residues involved in contacts are found on at least one 
monomer of each dimer. All other residues involved in crystal contacts are unique to 
each of these two structures. It is apparent from both these structures that almost all 
of the crystal contacts found in the KK68_nabhpl_1 are found in the 
KK68nabhpl2 structure. In addition to this the KK68nabhplj structure 
contains 8 unique crystal contacts whilst the KK68_nabhpl_2 contains only three 
unique contacts. The KK68nabhp12 structure also has considerably fewer 
contacts and it may be this lessening of crystal contacts is symptomatic of the 
diffraction streaking found in the KK68 nabhpl_2 crystal (Figure 9.3). Analysis of 
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the crystal contacts of both structures does not reveal a pattern to the unique crystal 
contacts and does not reveal a diminution of contacts along the b axis. 
Analysis of the crystal contacts of the other 3 new crystal forms established in this 
work reveals that the crystal contacts of these forms are highly variable and no 
contacts are conserved throughout all forms. 
It is apparent from the numbers of differing crystal contacts amongst the five new 
crystal forms presented here that no individual residues are ideally situated on the 
protein to form conserved crystal contacts throughout all crystal forms. This is not 
surprising as the polymorphism in both crystal forms and in the sizes of unit cells 
found for structures in the same crystal form (Table 9.1) would suggest a large 
degree of variation in the crystal contacts. It has been suggested by Lee [46] that the 
crystal contacts form "patches" of contact rather than discreet residue to residue 
interactions. This is also apparent in the structures presented here. 
Despite the solution of a crystal structure where the crystal had exhibited disorder of 
reflections in every second row this has not aided in the understanding of this crystal 
packing disorder. No explanation is immediately apparent from the crystal contacts, 
although it does have the fewest contacts of all reported crystal forms of type I 
dehydroquinase. It may be that this lack of contacts is suggestive of a relaxing of the 
crystal as a prelude to the more dramatic disordering exhibited in other crystals of 
this type. It does seem that these crystals are a mixture of two crystal forms with one 
changing into the other but why this is occurring is not clear. 
9.2 	The Hh loop in type I dehydroquinase. 
In all those native structures described both here and previously the Hh loop has 
been found to be in the more open position. The attempt to gain a native structure of 
the Gln 86 mutant protein failed because of the finding of acetate in the active site 
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although this structure (Gln_native_p2 1_i) does show that all that is required for 
loop closure is the presence of the hydrogen bond from Gin 236 into the active site. 
This structure also reveals the dynamic nature of the Hh loop. The method by which 
both the Gin nativep2ll and the Gln_soak_p21_1 were produced reveals that the 
Hh loop is capable of opening and closing within the crystal, or at the very least in 
this crystal form. it is reasonable to assume that prior to soaking of the 
Gln_soakp2ll crystal it was the same as the Gln_nativep2l_1 crystal, since both 
crystals came from the same drop. It is therefore likely that the Gln_soakp2 11 
crystal contained acetate within its active site. On the addition of dhq the Hh loop 
must have opened to allow the release of acetate and the insertion of dhq into the 
active site. If this were the case, then the addition of dhq triggered the breaking of 
the Gin 236—acetate hydrogen bond. A mechanism for this is not clear from 
comparison of both structures. It is more likely that the Hh loop is always dynamic 
in nature and is constantly opening and closing allowing the release of, and intake of, 
ligand, be it substrate I product or an inhibitor. The differences observed for the 
presence of ligand in different active sites in the same structures adds weight to this. 
It would normally be expected that each active site in the same structure would have 
a similar degree of occupied ligand but in both the Glnsoakp2ll structure and 
the kk68 inhib coxtalp2 11 structure the levels of occupied ligand in each active 
site are dramatically different. This is likely a result of the direct environment around 
each active site in the crystal but does serve to show the dynamic nature of the loop. 
It has previously been suggested by Lee [46] that the Hh loop in the native form 
type I dehydroquinase is stabilised in a more open position to allow access to the 
binding site. In the native structures reported here the Hh loop is in a more open 
form and is disordered in all cases. This would appear to agree with the suggestion 
that the dimer interface plays a role in the enzyme mechanism by facilitating access 
to the active site. The disordering of the Hh loop in these structures reveals the 
dynamic nature of the Rh loop and the Gly 235 - Ala 252 interaction probably 
serves as only a weak catch allowing the Hh loop to still move with a degree of 
freedom. This would allow the Rh loop to close over any ligand and so allow the 
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reaction to take place. Without this freedom of movement it is unclear how the Hh 
loop would be able to move into the active site. 
It therefore seems likely that the Hh loop is constantly moving between the open and 
closed formations. in the presence of ligand binding the equilibrium of this 
movement is shifted towards the closed conformation by the presence of the Gin 236 
- ligand hydrogen bond. In the absence of ligand this equilibrium is shifted towards 
the open conformation by the presence of the Gly 235 - Ala 252 hydrogen bond. 
Initially it would appear that the electron density of the structures described here 
would disagree with this as in those structures containing the substrate I product the 
Hh loop is well defined in density and is in the closed position. No evidence of 
movement is apparent in these structures. The growth conditions of these structures 
contain between 500 and 1000 times the Kd for the substrate I product and so the 
equilibrium in these crystals would be dramatically shifted towards the closed 
position. Those crystals containing inhibitor that were co-crystallised with ligand 
concentrations of about 5 times the Kd so show much more clearly the dynamic 
nature of the loop. The nature of the Hh loop and its role in the formation of the 
active site makes the Hh loop a target for inhibitory action. The GIn_nativep2 1_i 
reveals that the closing of the Hh loop is essential for the creation of the active site 
environment and hence the stabilising of ligand binding. The blocking of this closure 
may inhibit the enzyme's activity. It may be possible to remove the "catch" and so 
disrupt entry into the active site. This could feasibly be performed with 
carboxypeptidase which liberates C-terminal amino acid residues, with broad 
specificity [107]. 
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9.3 	Mechanism of type I dehydroquinase from S. 
typhi. 
Previous work on type I dehydroquinase has identified His 143 as being essential for 
the enzyme catalysis. This has been shown both chemically [39], by mutagenesis 
[41] and structurally [44]. All of this work has suggested that His 143 is the single 
ionising residue in dehydroquinase, which may act as the general base in the 
catalytic mechanism. Most recently this has been called into question [49] and it has 
been suggested that over the pH range 6 to 9.5 His 143 does not change its 
protonation state and so cannot act as the general base in the reaction mechanism. It 
has therefore been suggested that the general base in the mechanism could be either 
Lys 170 or Glu 86. It is likely that at the p1 of the enzyme the Lys 170 is not charged 
since alanine mutations of this lysine do not affect the p1 of the enzyme. It has 
therefore been suggested that the Glu 86 residue act as the general base in the 
reaction mechanism. 
The results presented here also suggest an important role for His 143 in the 
mechanism of type I dehydroquinase from S. typhi. The presence of both substrate 
and product in the active sites of the KK68_coxtalp 1_i structure (Chapter 5, 
section 5.3) makes this structure of particular interest with regards to the mechanism 
of enzyme action. This structure clearly shows movement of the His 143 sidechain 
between positions close to the C2 proton of the substrate/product and the side chain 
of Glu 86. This movement is primarily through rotation in chi I. Most interestingly of 
all is that the His 143 sidechain is closest to the C2 proton in the presence of 
substrate and is closer to the Glu 86 sidechain in the presence of product. This is in 
keeping with any proposed mechanism for the action of this enzyme. The distance of 
the His 143 NE2 atom from the C2 of the substrate is 3.0 A. This is the closest that 
rotation around only chi 1 will allow the His 143 NE2 to get to the C2 carbon of the 
substrate. In order for the reaction mechanism to proceed the C2 proton and His 143 
NE2 atom have to closely interact, this is not apparent in the structures reported here. 
Movements in the protein backbone would be required for the His 143 sidechain to 
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move any closer to the C2 proton of the substrate. No evidence for movement of this 
kind is apparent in any of the structures reported here. 
It is possible that the substrate undergoes a conformation change to move the C2 
proton closer to the His 143 NE2 atom. An alternative chair conformation has been 
suggested (R. Ramage, personal communication) that would allow the C2 proton to 













Figure 9.5. Diagram of the suggested conformational change of dhq in the active site of 
type I dehydroquinase. Left shows the known conformation of dhq and right shows the 
alternative chair conformation. 
A movement of this sort would result in the carboxyl group of the substrate 
becoming axial and the C I hydroxyl becoming equatorial. If the Cl and C6 carbons 
of the substrate were to stay in the same position as those found for the 
substrate/product in all reported X-ray structures the hydrogen bonds formed by the 
carboxyl group to Arg 213 and Gin 236 would be broken and the carboxyl group 
would be oriented towards Phe 225. The hydrophobic nature of Phe 225 makes this 
extremely unlikely and it is this nature and the strength of the hydrogen bonding 
network which could allow a large movement of the C2 and C6 carbons towards His 
143 and still conserve the hydrogen bonding network of the substrate. Modelling of 
this does result in the dramatic decrease in the C2 carbon to His 143 NE2 bond by at 
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Figure 9.6. Stereo diagram of type I dehydroquinase active site with dhq in alternative chair 
conformation modelled onto the structure of KK68_coxtal_pl_1. The interaction between His 
143 and C2 of the modelled dhq is indicated by a red dashed line (this distance is 2.1 A) 
Alternative chair co-ordination contains green carbons. (Modelling performed manually). 
The difference in free energy between these two forms has been calculated and 
found to be similar indicating that the alternative chair conformation of dhq is 
feasible (G. Ackland and L. Sawyer, persona! communication). This alternate 
conformation could therefore feasibly be a reaction intermediate.A further advantage 
of this alternative chair conformation is that the H1 proton is forced into an axial 
position and so is directed towards the NE2 of His 143. 
The evidence for the movement of His 143 would suggest that it is ideally positioned 
to act as the general base in the mechanism of type I dehydroquinase. The results of 
Leech [49] suggest this is not the case and have suggested the Glu 86 residue as 
being the general base with His 143 acting only as an intermediate. The evidence 
here suggests that Glu 86 is not the general base as none of the structures described 
here shows any movement in the Glu 86 loop or side chain. At no point therefore can 
the C2 proton, His 143 and Glu 86 all be interacting at the same time to allow this 
direct movement. A far greater movement in the substrate conformation and position 
would be required for this to occur and the evidence for the movement of His 143 
between the C2 of the substrate and the Glu 86 sidechain suggests this does not 
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The evidence from kinetic analysis of the Asp 86 and Gin 86 mutant enzymes also 
suggests that the Glu 86 is not the general base. Under the test conditions only the 
Asp 86 can be protonated whilst the Gin 86 cannot be. Therefore only the Asp 86 
can act as the general base. The kcat values of both of these mutant enzymes are very 
similar and suggest only a subtle change to the activity of the enzyme (Chapter 3, 
section 3.4). It could be expected that the Gin 86 mutant would cause a more 
dramatic effect to the enzyme activity if the Glu 86 residue was actually acting as the 
general base. Only mutations to the His 143 and the Lys 170 side chains result in 
dramatic decreases in enzyme activity [41]. It may be that in the Gln 86 the general 
base activity may be transferred to His 143 while in the Asp 86 mutant Asp 86 could 
still act as the general base, however in this case it is likely that a larger difference in 
the kcat of these mutants would be detected. The kcat of both these mutants would be 
expected to be similar if the effect of them was similar. From the structural 
information presented here the re-orientation of the 86 side chain to still allow 
interaction with the His 143 sidechain is the only noticeable effect of these 
mutations. It would seem likely that this weakens the interaction with His 143 and so 
weakens the ability of His 143 to move to and from the substrate / product. It is 
likely that this is the reason for the decrease in activity seen in these mutants and in 
the similarity the mutants have to each other. 
Taken together the evidence presented here suggests that His 143 is the general base 
in the mechanism of type I dehydroquinase. This could be tested using an Ala 
mutant of the His 143 residue. This mutant has been produced in E. coil and has 
been shown dramatically to decrease the activity of the enzyme. The addition of 
imidazole to this mutant might well result in the return of enzyme activity if His 143 
is acting as the general base. The Ala 143 mutant has a hole so adding imadazole 
should restore the activity of the enzyme. A precedent for this type of experiment 
working in type I dehydroquinase does exist. The activity of an Arg 82 to Ala mutant 




Structural solution and refinement of cytochrome c4 
from Pseudomonas aeruginosa. 
A1.1 	Introduction. 
The cytochrome C4 (cytC4) proteins are dihaem class I cytochromes (molecular 
mass approximately 20 kDa.) found in a variety of bacteria [108]. 
Five cytC4 proteins have been characterised and sequenced [109, 110, 111, 112]. 
The cytC4 proteins are found tightly bound to the membrane and in a free form 
[113, 114]. It has been proposed that they play an important role in aerobic 
respiration of (Gram-negative) bacteria [115], although detailed information about 
their exact role in the cell is not available. 
The crystallisation of cytochrome c4 from Pseudomonas aerurginosa and its 
resultant low resolution density map has previously been published [116]. This has 
not resulted in the solution and refinement of a high resolution structure however. 
This was due to there only being one good derivative which was on a special 
143 
position. Although Fe were known attempts to solve using these also failed and 
was likely due to poor data (Sawyer, personal communication) 
More recently the high resolution structure of cytochrome c4 from Pseudomonas 
stutzeri has been published [117]. Despite the high sequence homology of this 
protein to cytochrome c4 of Pseudomonas aeruginosa (Figure Al. I) initial attempts 
to solve the Pseudomonas aeruginosa structure utilising the Pseudomonas stutzeri 
structure as a search model in molecular replacement had also failed previously. 
NNKLLVSLLLTLGLTGLAHAACDAAAGQAKAAVCGACHGADCN PAPNFP KLAGQGERYL 
MNKVLVSLLLTLGITGNAHAAGDAEAGQGKVAVCGACHGVDGNS PAPNFPKLAGQGERYL 
LKQMHDIKDGK --------- ITVLEMIGLLTNLSDQDLAD1AAYFASQKMSVGMADPNL\ 
LKQLQDIKAGSTPGAPEGVGRKVLEMTGMLDPLSDQDLEDIAAYFSSQKGSVGYADPALA 
AQGEALFPGGKIAEGNPACTGCHS PSG VG 
KQGEKLFRGGKLDQGMPACTGCHAPNGVGNDLAGF PKLGGQHAAYTAKQLTDFREGNRTN 
DGDTKINQSIAAKLSNKDIAAISSYIQGLH 
DGDTMIMRGVAAKLSNKDI EAL S SYIQGLH 
Figure A1.1. Sequence alignment of cytochrome c4 sequences from Pseudomonas 
aeruginosa (top, coloured red) and Pseudomonas stutzeri (bottom, coloured black). Overall 
sequence identity is 76 %. Due to domain similarity several alignments are possible. 
As an exercise in molecular replacement the structural solution of cytochrome c4  
from Pseudomonas aeruginosa was attempted from a dataset previously collected at 
SRS Daresbury laboratory (data collected by B.Dhanjal). Data had previously been 
processed to a resolution of 1.95 A. Previous anomalous data had revealed the 
crystal spacegroup to be P61 22 (Unit cell a62.4A, b62.4A, c174.5A, c9O°, 
l39O0, y 1200) and not its enantimorph P6522 
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Al2 	Molecular replacement solution of Cytochrome C4 
from Pseudomonas aeruginosa. 
Attempts to obtain a molecular replacement solution using the complete 
Pseudomonas stutzeri structure failed again to give a believable rotation function 
solution (Table Al. 1). 
#Sol_ alpha beta gamma theta phi chi Rf 	Rf/sigma 
Sol_RF 1 27.84 63.18 49.42 44.57 79.21 96.56 0.7702E+05 3.80 
Sol_RF 2 32.16 116.82 229.42 114.97 171.37 139.98 0.7699E+05 3.80 
S01RF 3 25.71 153.45 37.69 82.93 84.01 157.47 0.7569E+05 3.74 
Sol_RF 4 34.29 26.55 217.69 163.74 178.30 110.23 0.7568E+05 3.74 
Sol_RF 5 27.29 145.15 22.90 82.42 92.20 148.53 0.7442E+05 3.68 
Sol_RF 6 7.58 127.85 287.65 104.69 129.97 136.42 0.74238+05 3.67 
Sol_RF 7 52.42 52.15 107.65 26.42 62.38 162.11 0.74228+05 3.66 
Sol-OF 8 52.42 63.23 352.29 58.29 120.07 76.09 0.73218+05 3.62 
Table A1.1. Top eight rotation functions using the complete Pseudomonas stutzeri 
monomer structure as a search model. 
Visual analysis of the Pseudomonas stutzeri structure [117] (pdb code 1 ETP) 
revealed the protein to be made up of two very similar but distinct domains (Figure 
A 1.2). 
Figure A1.2 	Overall structure of single monomer of cytochrome c4 from Pseudomonas 
stutzeri [117]. The N - terminal domain (residues 1 to 90) are coloured red and the C - 
terminal domain (residues 97 to 190) are coloured blue. 
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Molecular replacement was performed using each of these domains separately. The 
C terminal domain (residues 97 to 190) was found to give a believable rotation 
function solution (Table A1.2) and was subsequently used to gain a translation 
function solution (Table A 1.2). 
#Sol 	 alpha beta gamma theta phi chi 	 Rf Rf/sigma 
Sol_RF 1 28.70 150.53 334.87 89.53 116.91 150.54 0.4220E+05 3.73 
Sol_RF 2 	31.30 	29.47 154.87 165.24 -151.79 174.03 	0.4220E+05 3.73 
Sol_RF 3 22.49 153.42 328.15 91.10 117.17 153.51 0.4003E+05 3.54 
Sol_RF 4 10.49 64.47 309.43 118.52 120.53 74.75 0.3930E+05 3.47 
S01RF 5 49.51 115.53 129.43 57.78 50.04 179.44 0.3930E+05 3.47 
Sol_RF 6 	22.92 127.06 184.91 115.79 -170.99 167.69 	0.3818E+05 3.37 
Sol_RF 7 37.08 52.94 4.91 54.26 106.08 66.61 0.3818E+05 3.37 
Sol_RF 8 56.71 58.08 2.60 48.30 117.05 81.11 0.3710E+05 3.28 
#Sol_ 	alpha beta gamma theta phi chi 	 Rf Rf/sigma 
Sol_RF 1 12.22 61.78 348.31 89.56 101.96 61.78 0.3942E+05 5.72 
Sol_RF 2 	47.78 118.22 168.31 119.63 -150.27 161.70 	0.3942E+05 5.72 
Sol_RF 3 44.11 129.84 67.18 68.87 78.47 152.32 0.2689E+05 3.90 
Sol_RF 4 15.89 50.16 247.18 147.98 154.36 106.18 0.2689E+05 3.90 
Sol_RF 5 	1.51 124.55 280.02 108.39 130.75 137.76 0.2624E+05 3.80 
Sol_RF 6 58.49 55.45 100.02 28.14 69.23 161.00 0.2624E+05 3.80 
Sol_RF 7 32.87 65.17 1.70 65.07 105.58 72.87 0.2565E+05 3.72 
Sol_RF 8 21.42 50.06 262.66 142.80 149.38 88.81 0.2522E+05 3.66 
oI1'F I I 	12.22 	61.70 -11.69 0.379 0020 0,190 201.37 0.607 0H79 
Sol_TF_l 2 12.22 61.78 -11.69 0.369 0.016 0.204 100.23 0.601 0.297 
S01TF_1 3 12.22 61.78 -11.69 0.374 0.011 0.143 92.65 0.606 0.268 
Sal TF2 1 	47.78 118.22 168.31 0.377 0.358 0.477 181.27 0.572 0.357 
Sol...TF_2 2 47.78 118.22 168.31 0.376 0.353 0.463 104.11 0.607 0.294 
So1TF_2 3 47.78 118.22 168.31 0.372 0.358 0.024 97.09 0.606 0.280 
Table A1.2 	Rotation functions for both the N - terminal (top) and the C - terminal 
(middle) domains translation function peaks are shown for the C - terminal domain (bottom) 
and the used solution is coloured red. Used solution stems from the first rotation function 
peak for the C - terminal domain. 
A1..3 	Building and refinement of cytochrome c4 from 
Pseudomonas aeruginosa. 
After a solution was found with the Pseudomonas stutzeri sequence the resulting C 
terminal domain solutions sidechains were converted to the Pseudomonas 
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aeruginosa sequence according to its alignment and subjected to 10 cycles of 
REFMAC [76] rigid body refinement resulting in an R factor of 48 %. 
Analysis of resulting 2 IF0I-IF and  F0I-IFI  maps revealed the density for the input 
model to be excellent and after restrained refinement the map improved to the extent 
that density for large sections of the missing part of the structure could be 
interpreted. 
Although the result produced excellent phases and the resolution of the data was 
such that automated building was possible, it was found to be faster to build the 
remainder of the structure by eye. Fragments of the Pseudomonas stutzeri structure 
were fitted directly into F0I-IF  maps using the programme 0 [80] and then 
subjected to 5 cycles of REFMAC [76] restrained refinement. After each cycle of 
building and refinement, subsequent electron density maps were greatly improved 
and allowed complete building of all residues in the structure. The two haem groups 
were added after complete building and ARP-WARP [81] was used to add 90 waters 
which were checked manually. The final refinement statistics are shown in table 
A1.3. 
REFINEMENT 
RESOLUTION RANGE 	A 22.94 - 1.95 
REFLECTIONS USED (RFREESET) 14625 (768) 
RCRYST (RFiE) 	% 16.55 (19.03) 
R.M.S.D BOND LENGTHS A/ANGLES ° 0.03 	/ 2.15 
AVERAGE B MAIN CHAIN /SIDE CHAIN 25.79/27.94 
RAcRAN1l 	% IN MOST FAVOURED 92.6% 
ADDITIONAL ALLOWED 6.0% 
GENEROUSLY ALLOWED 0. 0% 
DISALLOWED 1.3% 
Table A1.3 	Refinement statistics for cytochrome c4 from Pseudomonas aeruginosa. 
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A1.4 	Structure analysis. 
The overall structure is predominately a - helical, comprising 9 ct—helices. The N 
and C terminal domains are linked by a 10 amino acid linking chain and each 
domain contains a single haem molecule (Figure Al .3). 
Figure A1.3. Overall structure of cytochrome c4 from Pseudomonas aeruginosa. 
All residues and the haem groups are found to be in excellent density (Figure A 1.4). 
Figure Al .4. 	Electron density around the N-terminal haem group. Electron density is of a 
21F.1-IFI map (produced using FFT [79]) and is contoured at 1 sigma. 
The density for both haem groups and their irons is also excellent. The exception to 
this excellent density is found between residues 116 to 126 which are in poorly 
defined density and therefore disordered. The two residues found within the 
disallowed region of the Rarnachandran plot (Ala 124 and Ser 115) are found in this 
disordered region. This region is on the exterior of the protein and is not involved in 
any crystallographic contacts. Despite its closeness to the haem interacting histidine 
114 the apparent mobility of this region appears to have no effect on the histidine 
stability which is well defined in density. Also of interest is the presence of well 
defined waters to be found on 2 fold crystallographic axes (Figure Al .5) which have 
been given half occupancy. 
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Figure A1.5. 	Electron density of a half occupied water resting by one of the 
crystallographic two-folds. Image created using the programme 0 [80]. Electron density is of 
a 2IF01-IF1 map (produced using FFT [79]) and is contoured at 1 sigma. 
When the Pseudomonas aeruginosa structure is overlayed onto the Pseudomonas 
stutzeri published cytochrome C4 structure (pdb code 1 ETP) the conformation of 
both structures is found to be near identical. The exception to this is a small loop 
which is present in the Pseudomonas stutzeri (residues 50 to 60) structure but absent 
in the Pseudomonas aeruginosa structure described here (Figure A 1.6). 
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Figure A1.6 	Overlay of Pseudomonas stutzeri (blue) cytochrome c4 monomer with that of 
Pseudomonas aeruginosa (red). The extended loop corresponding to residues 50 to 60 of 
the Pseudomonas stutzeri structure is circled. 
The high similarity in the secondary structure is mirrored in the high similarity in the 
haen-i binding environment of these structures. Both the Pseudomonas stutzeri 
structure and the structure reported here contain a pseudo-twofold axis centred at the 
highly defined by density haem interaction. This pseudo-twofold extends throughout 
the whole molecule (Figure A1.7) but lessens further away from the propionic acid - 
propionate hydrogen bond. The hydrogen bond network in this region also shows 
this 2 fold symmetry which extends to all water molecules in this region (Figure 
A1.7). 
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Figure A1.7. 	Schematics down pseudo - two fold axis. Left image is of overall structure. 
Right image is close up of haem - haem interaction with the pseudo two fold passing through 
the propionic acid propionate hydrogen bond. 
Few differences in the haem binding environment are present in this structure when 
compared to the Pseudomonas stutzeri structure. The presence of valine 137 in the 
structure reported here instead of Threonine 146 in the Pseudomonas stutzeri 
structure results in the presence of an additional water in the haem binding domain 
of the Pseudomonas stutzeri structure as the water is able to form a hydrogen bond 
to the OGI atom of the threonine sidechain. It was proposed by Kadziola [117] that 
the symmetrical hydrogen bonding network passing through the centre of the 
hydrogen bond connecting the haem groups from each domain is designed to assist 
intramolecular electron transport. This hydrogen bonding network is present in both 
the Pseudomonas stutzeri and Pseudomonas aeruginosa cytochrome c4 structures. 
The presence of the water interacting with threonine 146 in the Pseudomonas 
stutzeri perturbs this network and the reported symmetry breaks down. The absence 
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of this threonine in the Pseiidomonas aeruginosa cytochrome c4 structure and its 
resultant interacting water may therefore explain the differences in the mid point 
potentials (E111 (mV) = 322, 268 P. aeruginosa, 300, 190 P. stutzeri [114]) between 
these two proteins (Figure A! .8). 
Figure A1.8. Overlay of threonine 146 of Pseudomonas stutzeri and valine 137 of 
Pseudomonas aeruginosa. Two waters are shown bonding to threonine 146 in the 
Pseudomonas stutzeri structure that are not present in the Pseudomonas aeruginosa 




The similarity of the structure reported here compared to the previous published 
Pseudomonas stutzeri structure is not surprising considering the high sequence 
identity between the two structures. In view of this fact it is surprising that no 
obvious rotation function solution was obtained when the whole Pseudomonas 
stutzeri monomer structure was used as a search model. This may be to do with the 
high symmetry of the crystals (Professor Randy Read, personal communication) 
which effectively masks the rotation function. However this does not explain why a 
single domain resulted in two obvious rotation function solutions both of which were 
able to give a correct solution. These solutions are indicative of the high structural 
similarity between the N and C terminal haem-binding domains. 
The difference in the overall structure of Pseudomonas aeruginosa C4 with that of 
Pseudomonas stutzeri is confined to the absence of the 50 to 60 loop in the structure 
reported here. No mechanistic significance can be attributed to this loop however 
and it is unlikely that this is the reason for the difference in the electric potentials 
between these two structures. Although it is adjacent to the haem interacting His 114 
and so cannot be discounted as playing a role. 
Subtle differences between the haem binding interactions of both proteins are more 
likely to be a reason for this. In this aspect both structures are again very similar with 
only one significant difference. The first of these is in the pseudo-twofold axis. 
Comparison of both structures reveals their side chain hydrogen bonding network to 
be nearly identical for the haem - haem interaction region. This is broken in the 
Pseudomonas stutzeri structure by the presence of a water molecule that interacts 
directly with the propionic acid - propionate interaction and is unreported in the 
original paper. This water molecule is not present in the structure reported here 
(Figure Al .8). The reason for the presence of this water in the Pseudomonas stutzeri 
structure is the presence of threonine 146 which allows the hydrogen bonding of 
water to its OG1 oxygen. This water also binds to one of the two highly defined 
154 
waters that are directly interacting with the propionic acid - propionate hydrogen 
bond. This may have the effect of disrupting this interaction in a manner that affects 
the midpoint potential. Modelling of the Azotobacter vinelandii cytochrome c4 
sequence has been performed based on the Pseudomonas stutzeri cytochrome c4 
structure. In the model the haem binding pockets for both domains are near identical 
to those of Pseudomonas stutzeri and Pseudomonas aeruginosa. It is interesting to 
note that in the threonine 146 position of Pseudomonas stutzeri Azotobacter 
vinelandii contains a valine. The midpoint potentials of Azotobacter vinelandii (317 
mV, 263 mV) also differ to those of Pseudomonas stutzeri and are similar to those of 
Pseudomonas aeruginosa, which also contains a valine at this position. 
The presence of threonine 146 and its water also breaks up the pseudo symmetry 
much closer to its origin than was suggested in the original structure paper. This 
does not occur in the structure reported here as the valine 137 is related to leucine 40 
in the N —terminal domain. Although these are different amino acids and so do not 
truly obey the pseudo-symmetry they take up near identical positions and interact 
with their neighbouring molecules in similar ways to each other. They therefore do 
not break down the 2 fold hydrogen bonding network. It would be of interest to 
mutate Thr 146 to Val in the P. stutzeri protein to establish if this results in a 
difference to the P. stutzeri mid point potential. 
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